Recombinant microorganisms and their uses
Recombinant microorganisms engineered with β-alanine pathway enzymes convert CO and CO2 into 3-HP, addressing inefficiencies in current production methods and reducing pollution by utilizing industrial gases.
Patent Information
- Application Number
- JP2023521339
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2021-02-08
- Filing Date
- 2022-02-07
- Publication Date
- 2024-12-09
- Estimated Expiration
- 2042-02-07
AI Technical Summary
Current methods for producing 3-hydroxypropionic acid (3-HP) are inefficient and do not effectively utilize carbon monoxide (CO) and carbon dioxide (CO2) from industrial processes, leading to environmental pollution.
Engineering recombinant microorganisms with enzymes from the β-alanine pathway to convert CO and/or CO2 into 3-HP through the Wood-Ljungdahl pathway, combining fixed pathways for sustainable fermentation.
Achieves higher titers and productivity of 3-HP from gaseous substrates, providing an alternative to current methods and reducing environmental pollution by utilizing industrial CO and CO2.
Smart Images

Figure 0007596523000006 
Figure 0007596523000007 
Figure 0007596523000008
Abstract
Description
[Technical field]
[0001] (CROSS REFERENCE TO RELATED APPLICATIONS) This application claims the benefit of U.S. Provisional Patent Application No. 63 / 147,108, filed February 8, 2021, the entirety of which is incorporated herein by reference.
[0002] (Government Rights) This disclosure was made with Government support under Agreement No. DE-SC0019090 awarded by the U.S. Department of Energy. The Government has certain rights in this invention.
[0003] FIELD OF THEINVENTION The present disclosure relates to recombinant microorganisms and methods for the production of 3-hydroxypropionic acid [3-HP] by microbial fermentation of substrates containing CO and / or CO2. [Background technology]
[0004] 3-Hydroxypropionic acid [3-HP] is a platform chemical that acts as a precursor and as a chemical feedstock for the production of polymeric materials. Poly(3-hydroxypropionic acid) [P(3-HP)] is a biodegradable polymer with promising properties such as very high thermal stability.
[0005] 3-HP can be used to derive many valuable industrial chemicals, including acrylic acid, used in the production of paints, paper, adhesives, textiles, specialty coatings, inks, and the superabsorbent polymer polyacrylate; 1,3-propanediol, useful to produce polytrimethylene terephthalate, used as a solvent, adhesive, cosmetics, or in carpets and textiles; and 3-hydroxypropionaldehyde, used in food preparation, as a feed additive, and as a preservative in the nutritional industry.
[0006] 3-HP is listed as the third most important renewable chemical by the U.S. Department of Energy, and the global market for 3-HP is estimated to be 3.63 million tons per year (Sauer et al, 2008, Bozell et al, 2010, US DOE report: 48-49). Summary of the Invention
[0007] It is an object of the present disclosure to provide recombinant microorganisms and methods for the production of 3-HP by microbial fermentation that may offer one or more advantages over known methods, or at least provide the public with a useful choice.
[0008] The present disclosure generally provides, inter alia, methods for the production of 3-HP by microbial fermentation of substrates containing CO and / or CO2, and recombinant microorganisms useful in such methods, which combine two distinct CO2 fixation pathways to produce a single metabolic product.
[0009] In a first aspect, the present disclosure provides an anaerobic acetogenic recombinant microorganism capable of producing 3-HP and optionally one or more other products by fermentation of a substrate comprising CO and / or CO2.
[0010] In one particular embodiment, the microorganism is adapted to express one or more enzymes (or one or more subunits thereof) in the 3-HP biosynthetic pathway, which enzymes are not naturally present in the parental microorganism from which the recombinant microorganism is derived. In another embodiment, the microorganism is adapted to overexpress one or more enzymes (or one or more subunits thereof) in the 3-HP biosynthetic pathway, which enzymes are naturally present in the parental microorganism from which the recombinant microorganism is derived. In one embodiment, the microorganism is adapted to express one or more enzymes (or one or more subunits thereof) in the 3-HP biosynthetic pathway that are not naturally present in the parental microorganism and overexpress one or more enzymes (or one or more subunits thereof) in the 3-HP biosynthetic pathway that are naturally present in the parental microorganism.
[0011] In one embodiment, the one or more enzymes are selected from the group consisting of β-alanine pyruvate aminotransferase (BAPAT) (EC 2.6.1.19), malonic semialdehyde reductase (MSR) (EC 1.1.1.59 and EC 1.1.1.295), acetyl-CoA carboxylase (ACC) (EC 6.4.1.2), and a functionally equivalent variant of any one of them.
[0012] In one embodiment, the parental microorganism is capable of fermenting a substrate containing CO and / or CO to produce acetyl-CoA but is unable to convert acetyl-CoA to 3-HP, and the recombinant microorganism is adapted to express one or more enzymes (or one or more subunits thereof) involved in the conversion of acetyl-CoA to 3-HP.
[0013] In one embodiment, the microorganism comprises one or more exogenous nucleic acids adapted to increase expression of one or more nucleic acids native to the parent microorganism, the one or more nucleic acids encoding one or more of the enzymes (or one or more subunits thereof) described herein above.
[0014] In one embodiment, the one or more exogenous nucleic acids adapted to increase expression are regulatory elements, hi one embodiment, the regulatory element is a promoter.
[0015] In one embodiment, the promoter is a constitutive promoter. In one embodiment, the promoter is selected from the group comprising the Wood-Ljungdahl gene cluster or the phosphotransacetylase / acetate kinase operon promoter.
[0016] In one embodiment, the microorganism comprises one or more exogenous nucleic acids adapted to encode and express one or more of the enzymes (or one or more subunits thereof) described herein above, In one embodiment, the microorganism comprises one or more exogenous nucleic acids adapted to encode and express at least two of the enzymes (or one or more subunits thereof).
[0017] In one embodiment, the one or more exogenous nucleic acids are nucleic acid constructs or vectors, which in one particular embodiment are plasmids encoding one or more of the above mentioned enzymes, in any combination.
[0018] In one embodiment, the exogenous nucleic acid is an expression plasmid.
[0019] In one embodiment, the parent microorganism is selected from the group of anaerobic acetogens.
[0020] In one particular embodiment, the parent microorganism is selected from the group of carboxydotrophic acetogenic bacteria, in one embodiment selected from the group comprising Clostridium autoethanogenum, Clostridium ljungdahlii, Clostridium ragsdalei, Clostridium carboxidivorans, Clostridium drakei, Clostridium scatologenes, Clostridium aceticum, Clostridium formicoaceticum, Clostridium magnum, Butyribacterium methylotrophicum, Acetobacterium woodii, Alkalibaculum bacchii, Blautia producta, Eubacterium limosum, Moorella thermoacetica, Moorella thermautotrophica, Sporomusa ovata, Sporomusa silvacetica, Sporomusa sphaeroides, Oxobacter pfennigii, and Thermoanaerobacter kivui.
[0021] In one embodiment, the parent microorganism is Clostridium autoethanogenum or Clostridium ljungdahlii. In one particular embodiment, the microorganism is Clostridium autoethanogenum DSM 23693. In another particular embodiment, the microorganism is Clostridium ljungdahlii DSM 13528 (or ATCC 55383).
[0022] In one embodiment, the parental microorganism lacks one or more genes encoding β-alanine pyruvate aminotransferase and / or acetyl-CoA carboxylase, or one or more subunits thereof.
[0023] In a second aspect, the disclosure provides nucleic acids encoding one or more enzymes (or one or more subunits thereof) that, when expressed in a microorganism, enable the microorganism to produce 3-HP by fermentation of a substrate comprising CO and / or CO2.
[0024] In one embodiment, the nucleic acid encodes two or more enzymes (or one or more subunits thereof) that, when expressed in a microorganism, enable the microorganism to produce 3-HP by fermentation of a substrate that includes CO.
[0025] In one embodiment, the enzyme is selected from β-alanine pyruvate aminotransferase and acetyl-CoA carboxylase, and functionally equivalent variants of any one or more thereof.
[0026] In one embodiment, the nucleic acid comprises nucleic acid sequences encoding β-alanine pyruvate aminotransferase, acetyl-CoA carboxylase, or functionally equivalent variants of any one or more thereof, in any order.
[0027] In one embodiment, the nucleic acid encoding the β-alanine pyruvate aminotransferase has the sequence of SEQ ID NO: 13, or a functionally equivalent variant thereof. In one embodiment, the nucleic acid encoding the β-alanine pyruvate aminotransferase has the sequence of SEQ ID NO: 14, or a functionally equivalent variant thereof. In one embodiment, the nucleic acid encoding the β-alanine pyruvate aminotransferase has the sequence of SEQ ID NO: 15, or a functionally equivalent variant thereof.
[0028] In one embodiment, the nucleic acid of the present disclosure further comprises a promoter. In one embodiment, the promoter allows for constitutive expression of the gene under its control. In one particular embodiment, the Wood-Ljungdahl cluster promoter is used. In another particular embodiment, the phosphotransacetylase / acetate kinase operon promoter is used. In one particular embodiment, the promoter is derived from C. autoethanogenum.
[0029] In a third aspect, the present disclosure provides a nucleic acid construct or vector comprising one or more nucleic acids of the second aspect.
[0030] In a particular embodiment, the nucleic acid construct or vector is an expression construct or vector. In a particular embodiment, the expression construct or vector is a plasmid.
[0031] In a fourth aspect, the present disclosure provides a host organism comprising any one or more of the nucleic acids of the seventh aspect or the vectors or constructs of the third aspect.
[0032] In a fifth aspect, the present disclosure provides a composition comprising an expression construct or vector referred to in the third aspect of the disclosure and a methylation construct or vector.
[0033] Preferably, the composition is capable of producing a recombinant microorganism according to the first aspect of the present disclosure.
[0034] In a particular embodiment, the expression construct / vector and / or the methylation construct / vector is a plasmid.
[0035] In a sixth aspect, the present disclosure provides a method for the production of 3-HP, and optionally one or more other products, by microbial fermentation comprising fermenting a substrate comprising CO and / or CO2 using a recombinant microorganism of the first aspect of the disclosure.
[0036] In one embodiment, the method comprises: (a) providing a substrate comprising CO and / or CO2 to a bioreactor containing a culture of one or more microorganisms of the first aspect of the present disclosure; (b) anaerobically fermenting the culture in a bioreactor to produce 3-HP.
[0037] In one embodiment, the method comprises: (a) capturing gases containing CO and / or CO2 produced as a result of an industrial process before the gases are released into the atmosphere; (b) anaerobically fermenting the gas containing CO and / or CO2 by a culture containing one or more microorganisms of the first aspect of the present disclosure to produce at least 3-HP.
[0038] In certain embodiments of the method aspects, the microorganism is maintained in an aqueous culture medium.
[0039] In certain embodiments of the method aspects, fermentation of the substrate is carried out in a bioreactor.
[0040] Preferably, the substrate comprising CO and / or CO2 is a gaseous substrate comprising CO and / or CO2. In one embodiment, the substrate comprises an industrial waste gas. In a particular embodiment, the gas is a steel mill waste gas or a synthesis gas.
[0041] In one particular embodiment, the substrate is a CO-containing substrate.
[0042] In embodiments of the present disclosure in which the substrate comprises CO2 but not CO, the substrate preferably also comprises H2.
[0043] In one embodiment, the substrate comprises CO and CO. In one embodiment, the substrate comprises CO and H. In another embodiment, the substrate comprises CO, CO, and H.
[0044] In one embodiment, the substrate typically contains a major proportion of CO, such as at least about 20% to about 100% CO by volume, 20% to 70% CO by volume, 30% to 60% CO by volume, and 40% to 55% CO by volume. In certain embodiments, the substrate contains about 25% by volume, or about 30% by volume, or about 35% by volume, or about 40% by volume, or about 45% by volume, or about 50% by volume CO, or about 55% by volume CO, or about 60% by volume CO.
[0045] In certain embodiments, the method further comprises recovering 3-HP, and optionally one or more other products, from the fermentation broth.
[0046] In a seventh aspect, the disclosure provides 3-HP when produced by the method of the sixth aspect.
[0047] In another aspect, the disclosure provides a method for the production of a microorganism of the first aspect of the disclosure, comprising transforming a parental microorganism with one or more exogenous nucleic acids such that the microorganism is capable of producing 3-HP and optionally one or more other products by fermentation of a substrate comprising CO and / or CO2, wherein the parental microorganism is not capable of producing 3-HP by fermentation of a substrate comprising CO and / or CO2.
[0048] In one particular embodiment, the parental microorganism is transformed with one or more exogenous nucleic acids adapted to express one or more enzymes in a 3-HP biosynthetic pathway that are not naturally occurring in the parental microorganism. In another embodiment, the parental microorganism is transformed with one or more nucleic acids adapted to express one or more enzymes in a 3-HP biosynthetic pathway that are naturally occurring in the parental microorganism. In another embodiment, the parental microorganism is transformed with one or more exogenous nucleic acids adapted to express one or more enzymes in a 3-HP biosynthetic pathway that are not naturally occurring in the parental microorganism and to overexpress one or more enzymes in a 3-HP biosynthetic pathway that are naturally occurring in the parental microorganism.
[0049] In certain embodiments, the one or more enzymes are as described herein above.
[0050] In certain embodiments, the parent microorganism is as previously described herein.
[0051] According to one embodiment, a process for converting CO or CO2 to 3-hydroxypropionic acid (3-HP) is provided. A gaseous CO-containing and / or CO2-containing substrate is passed through a bioreactor containing a culture of carboxydotrophic acetogens in a culture medium such that the bacteria convert the CO and / or CO2 to 3-HP. The carboxydotrophic acetogen bacteria are genetically engineered to express β-alanine pyruvate aminotransferase. They also express acetyl-CoA carboxylase, whether native or exogenous. 3-HP is recovered from the bioreactor.
[0052] According to another embodiment, an isolated engineered carboxydotrophic acetogenic bacterium is provided, comprising a nucleic acid encoding a β-alanine pyruvate aminotransferase. The nucleic acid is foreign to the host bacterium. The bacterium expresses the β-alanine pyruvate aminotransferase, and the bacterium acquires the ability to produce malonic semialdehyde via a transamination reaction with pyruvate and β-alanine. The β-alanine pyruvate aminotransferase is typically at least 85% identical to the amino acid sequence encoded by the nucleotide sequence of SEQ ID NO: 13. The β-alanine pyruvate aminotransferase is typically at least 85% identical to the amino acid sequence encoded by the nucleotide sequence of SEQ ID NO: 14. The β-alanine pyruvate aminotransferase is typically at least 85% identical to the amino acid sequence encoded by the nucleotide sequence of SEQ ID NO: 15. In one embodiment, the β-alanine pyruvate aminotransferase is selected because pyruvate is a central metabolic product and a cofactor that provides distinct advantages, such as driving enzyme flux.
[0053] The bacterium may further comprise an exogenous nucleic acid encoding an acetyl-Coenzyme A carboxylase. The nucleic acid may be operably linked to a promoter. The nucleic acid may be codon optimized. The nucleic acid or the encoded carboxylase may be from a non-sulfur photosynthetic bacterium. Bacteria include Clostridium autoethanogenum, Clostridium ljungdahlii, Clostridium ragsdalei, Clostridium carboxidivorans, Clostridium drakei, Clostridium scatologenes, Clostridium aceticum, Clostridium formicoaceticum, Clostridium magnum, Butyribacterium methylotrophicum, Acetobacterium woodii, Alkalibaculum bacchii, Blautia producta, Eubacterium limosum, Moorella thermoacetica, Moorella thermautotrophica, Sporomusa ovata, Sporomusa silvacetica, Sporomusa sphaeroides, Oxobacter pfennigii, and Thermoanaerobacter kivui. The donor bacterium for the exogenous nucleic acid may be a non-sulfur photosynthetic bacterium, such as Chloroflexus aurantiacus, Metallosphaera, and Sulfolobus spp.
[0054] The genetically engineered bacteria can be cultured by growing in a medium containing a gaseous carbon source. The carbon source may include CO and / or CO2, which may be used as either or both an energy source or a carbon source. The bacteria can optionally be grown under strictly anaerobic conditions. The carbon source may include industrial waste or off-gas.
[0055] The present disclosure may also be broadly described as consisting in any or all combinations of two or more of the moieties, elements and features referred to or shown in the specification of this application, either individually or collectively, and where a specific integer having known equivalents in the art to which this disclosure pertains is referred to herein, such known equivalents are deemed to be incorporated herein as if individually set forth.
[0056] These and other aspects of the present disclosure, which is to be considered in all its novel aspects, will become apparent from the following description, given by way of example only, with reference to the accompanying drawings, in which: [Brief description of the drawings]
[0057] [Figure 1]Metabolic pathways leading to the biosynthesis of 3-hydroxypropionic acid (3-HP) and 1,3-propanediol (1,3-PDO) by Clostridium autoethanogenum from gas fermentation. Enzymatic steps requiring heterologous expression are shown in black, and native reactions are shown in grey. Carbon and hydrogen are assimilated to acetyl-CoA by the Wood-Ljungdahl pathway (WLP), which is then converted to pyruvate by pyruvate:ferredoxin oxidoreductase (PFOR). L-aspartate is formed by the action of pyruvate carboxylase (PYC), malate dehydrogenase (MDH), fumarate hydratase (FH), aspartate ammonia-lyase (AAL), and aspartate aminotransferase (AAT). Aspartate-4-decarboxylase (ADC) then converts L-aspartate to L-alanine. The key pathway intermediate β-alanine can be synthesized from L-aspartate via heterologous expression of aspartate-1-decarboxylase (PAND) or from L-alanine via 2,3-alanine aminomutase (AAM). Alanine dehydrogenase (ALADH) can be heterologously expressed to convert pyruvate to L-alanine. β-alanine pyruvate aminotransferase (BAPAT) and / or γ-aminobutyrate transaminase (GABT) can then convert β-alanine to malonate semialdehyde, which is then reduced to 3-HP via malonate semialdehyde (MSR). Alanine transaminase (AT) can be heterologously expressed to convert L-alanine to pyruvate for the BAPAT reaction. Glutamate dehydrogenase (GDH) can be heterologously expressed to convert glutamate to α-ketoglutarate for the GABT reaction.1,3-PDO can be produced from 3-HP through the action of aldehyde:ferredoxin oxidoreductase (AOR) and alcohol dehydrogenase (ADH). NAD(P)H includes NADPH and NADH. [Figure 2A] Figure 2 shows the autotrophic growth of Clostridium autoethanogenum Δaor strain in the presence of different amounts of 3-hydroxypropionic acid (0, 0.2, 0.5, 1, 2, 5 and 10 g / L) in Schott bottles. Figure 2A: Growth profile. Unc = unchallenged; N = 2; error bars = SD. [Figure 2B] Figure 2B shows autotrophic growth of Clostridium autoethanogenum Δaor strain in the presence of different amounts of 3-hydroxypropionic acid (0, 0.2, 0.5, 1, 2, 5 and 10 g / L) in Schott bottles. Figure 2B: Peak biomass. Unc = unchallenged; N = 2; error bars = SD. [Diagram 3] We show that Clostridium autoethanogenum can convert exogenous 3-hydroxypropionic acid to 1,3-propanediol during autotrophic growth in Schott bottles. Deletion of aldehyde:ferredoxin oxidoreductase (AOR) abolishes this native reaction occurring in C. autoethanogenum. N=2; error bars=SD. [Figure 4] 1 shows the combinatorial assembly of 3-hydroxypropionate pathway genes using the Golden Gate (GG) method. [Figure 5A] Characterization of 111 3-hydroxypropionic acid (3-HP) combinatorial strains in 12-well plates using a syngas blend (50% CO, 10% H2, 30% CO2, and 10% N2) at 200 kPa. Figure 5A: Endpoint 3-HP titers. [Figure 5B]Characterization of 111 3-hydroxypropionic acid (3-HP) combinatorial strains in 12-well plates using a syngas blend (50% CO, 10% H2, 30% CO2, and 10% N2) at 200 kPa. Figure 5B: Biomass concentration. [Figure 5C] Characterization of 111 3-hydroxypropionic acid (3-HP) combinatorial strains in 12-well plates using a syngas blend (50% CO, 10% H, 30% CO, and 10% N) at 200 kPa. Figure 5C: 3-HP titer normalized by biomass concentration; incubation period = 8 days. [Figure 6] Peak 3-hydroxypropionic acid titers from combinatorial and WT C. autoethanogenum strains during autotrophic growth in Schott bottles. Incubation period = 14 days; N = 2; error bars = SD. [Figure 7A] Performance of combinatorial strain A59B in batch CSTR fermentation using a syngas blend (50% CO, 10% H, 30% CO, and 10% N). Figure 7A: Biomass and metabolite profile analyzed by HPLC. [Figure 7B] Performance of combinatorial strain A59B in batch CSTR fermentation using a syngas blend (50% CO, 10% H, 30% CO, and 10% N). Figure 7B: Gas profile analyzed by GC-TCD (negative = uptake). [Figure 7C] Performance of combinatorial strain A59B in batch CSTR fermentation using a syngas blend (50% CO, 10% H, 30% CO, and 10% N). Figure 7C: 3-HP and 1,3-PDO profiles analyzed by LC-MS and GC-MS, respectively. [Figure 8A] Performance of combinatorial strain B2A in batch CSTR fermentation using a syngas blend (50% CO, 10% H, 30% CO, and 10% N). Figure 8A: Biomass and metabolite profile analyzed by HPLC. [Figure 8B] Performance of combinatorial strain B2A in batch CSTR fermentation using a syngas blend (50% CO, 10% H, 30% CO, and 10% N). Figure 8B: Gas profile analyzed by GC-TCD (negative = uptake). [Figure 8C] Performance of combinatorial strain B2A in batch CSTR fermentation using a syngas blend (50% CO, 10% H, 30% CO, and 10% N). Figure 8C: 3-HP and 1,3-PDO profiles analyzed by LC-MS and GC-MS, respectively. [Figure 9A] Figure 9 shows the performance of combinatorial strain A63B in batch CSTR fermentation using a syngas blend (50% CO, 10% H, 30% CO, and 10% N). Figure 9A: Biomass and metabolite profile analyzed by HPLC. [Figure 9B] Performance of combinatorial strain A63B in batch CSTR fermentation using a syngas blend (50% CO, 10% H, 30% CO, and 10% N). Figure 9B: Gas profile analyzed by GC-TCD (negative = uptake). [Figure 9C] Performance of combinatorial strain A63B in batch CSTR fermentation using a syngas blend (50% CO, 10% H2, 30% CO2 and 10% N2). Figure 9C: 3-HP and 1,3-PDO profiles analyzed by LC-MS and GC-MS, respectively. [Figure 10A] Figure 10 shows the performance of combinatorial strain A59B in continuous CSTR fermentation using a syngas blend (50% CO, 10% H2, 30% CO2 and 10% N2). Figure 10A: Biomass and metabolite profile analyzed by HPLC. [Figure 10B]Performance of combinatorial strain A59B in continuous CSTR fermentation using a syngas blend (50% CO, 10% H, 30% CO, and 10% N). Figure 10B: Gas profile analyzed by GC-TCD (negative = uptake). [Figure 10C] Performance of combinatorial strain A59B in continuous CSTR fermentation using a syngas blend (50% CO, 10% H2, 30% CO2 and 10% N2). Figure 10C: 3-HP and 1,3-PDO profiles analyzed by LC-MS and GC-MS, respectively. D = dilution rate / day. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0058] The following description of the embodiments is given in general terms, and the disclosure will be further clarified from the disclosure provided herein below under the heading "Examples," which provides experimental data supporting the disclosure, specific examples of various aspects of the disclosure, and means for practicing the disclosure.
[0059] The present inventors have surprisingly been able to engineer carboxydotrophic acetogenic microorganisms to 3-hydroxypropionic acid (3-HP) by fermentation of substrates containing CO and / or CO2. This provides an alternative means for the production of 3-HP that may have advantages over current methods for the production of 3-HP. Furthermore, it provides a means to use carbon monoxide from industrial processes that would otherwise be released into the atmosphere and pollute the environment. In the present disclosure, the microorganisms expressed enzymes from the β-alanine pathway, which resulted in 3-HP with significantly higher titers and prolificacy from gaseous substrates.
[0060] In engineering the microorganisms of the present disclosure, the inventors have surprisingly been able to combine two separate CO2 fixation pathways as shown in Figure 1. This provides a sustainable fermentation using a CO-containing substrate and / or a CO2-containing substrate to produce 3-HP. Thus, two pathways for fixing CO2 are linked to produce the desired product.
[0061] In one embodiment, the present disclosure describes the fixation of 3 molecules of CO2 into 1 molecule of 3-HP by combining two separate CO2 fixation pathways (Figure 1): the acetogenic Wood-Ljungdahl pathway, which allows the fixation of 2 molecules of CO2, and the initial carbon fixation step of the 3-HP cycle, which allows the fixation of another molecule of CO2. As a key enzyme of the Wood-Ljungdahl pathway, CO2 can also be replaced by CO, and CO dehydrogenase (CODH) can convert CO to CO2 and energy in the biological water gas shift reaction (CO+H2O<->CO2+H2). Any mixture of CO and CO2 can be used. CO can function as both carbon and energy source, although energy in the form of hydrogen or electricity may need to be provided if only CO2 is used.
[0062] Although the inventors have demonstrated the effectiveness of the present disclosure in Clostridium autoethanogenum, the present disclosure is applicable to a broader group of anaerobic acetogenic microorganisms and fermentation on substrates containing CO and / or CO2, as discussed above and further herein.
[0063] Unless otherwise stated, the following terms used throughout the specification are defined as follows:
[0064] The terms "enhancing efficiency," "increasing efficiency," and the like, when used in reference to a fermentation process, include, but are not limited to, increasing one or more of the following: increasing the growth rate of the microorganism catalyzing the fermentation, the growth and / or product production rate at elevated product concentrations, increasing the volume of desired product produced per volume of substrate consumed, increasing the production rate or level of the desired product, and increasing the relative proportion of the desired product produced compared to other by-products of fermentation, reducing the amount of water consumed by the process, and reducing the amount of energy utilized by the process.
[0065] The term "fermentation" should be interpreted as a metabolic process that causes a chemical change in a substrate. For example, a fermentation process receives one or more substrates and produces one or more products through the utilization of one or more microorganisms. Terms such as "fermentation", "gas fermentation" and the like should be interpreted as a process that receives one or more substrates, such as syngas produced by gasification, and produces one or more products through the utilization of one or more C1 fixing microorganisms. Preferably, the fermentation process includes the use of one or more bioreactors. The fermentation process can be described as either "batch" or "continuous". "Batch fermentation" is used to describe a fermentation process in which a bioreactor is filled with feedstock, i.e., a carbon source, along with microorganisms, and the product remains in the bioreactor until the fermentation is complete. In a "batch" process, after the fermentation is complete, the product is extracted and the bioreactor is washed before the next "batch" begins. "Continuous fermentation" is used to describe a fermentation process in which the fermentation process is extended for a longer period of time and products and / or metabolites are extracted during the fermentation. Preferably, the fermentation process is continuous.
[0066] The term "non-naturally occurring" when used in reference to a microorganism is intended to mean that the microorganism has at least one genetic modification that is not found in naturally occurring strains of the referenced species, including wild-type strains of the referenced species. Non-naturally occurring microorganisms are typically developed in a laboratory or research facility.
[0067] The terms "genetic modification," "genetic alteration," or "genetic engineering" refer broadly to the manipulation of the genome or nucleic acid of a microorganism by man. Similarly, the terms "genetically modified," "genetically altered," or "genetically engineered" refer to a microorganism that includes such a genetic modification, genetic alteration, or genetic engineering. These terms may be used to distinguish between laboratory-produced and naturally occurring microorganisms. Methods of genetic modification include, for example, heterologous gene expression, gene or promoter insertion or deletion, nucleic acid mutation, altered gene expression or inactivation, enzyme engineering, directed evolution, knowledge-based design, random mutagenesis, gene shuffling, and codon optimization.
[0068] For example, metabolic engineering of microorganisms such as Clostridia can greatly expand their ability to produce many important fuels and chemical molecules other than natural metabolites such as ethanol. However, until recently, Clostridia was considered genetically intractable and therefore generally off-limits to extensive metabolic engineering efforts. In recent years, several different methods for genome engineering have been developed for Clostridia, including intron-based methods (Kuehne, Strain Eng: Methods and Protocols, 389-407, 2011), allelic exchange methods (ACE) (Heap, Nucl Acids Res, 40:e59, 2012; Ng, PLoS One, 8:e56051, 2013), triple cross (Liew, Frontiers Microbiol, 7:694, 2016), I-SceI-mediated methods (Zhang, Journal Microbiol Methods, 108:49-60, 2015), MazF (Al-Hinai, Appl Environ Microbiol, 78:8112-8121, 2012), or others (Argyros, Appl Environ Microbiol, 77:8288-8294, 2011), Cre-Lox (Ueki, mBio, 5:e01636-01614, 2014), and CRISPR / Cas9 (Nagaraju, Biotechnol Biofuels, 9:219, 2016). However, repeatedly introducing more than a few genetic changes remains very challenging due to slow, laborious cycle times, and limitations on the inducibility of these genetic techniques across species. Furthermore, we do not yet understand C1 metabolism in Clostridia well enough to reliably predict modifications that will maximize carbon / energy / redox blow toward C1 uptake, conversion, and product synthesis. Thus, introduction of targeted pathways in Clostridia remains a tedious, time-consuming process.
[0069] "Recombinant" indicates that a nucleic acid, protein, or microorganism is the product of genetic modification, manipulation, or recombination. Generally, the term "recombinant" refers to a nucleic acid, protein, or microorganism that contains or is encoded by genetic material derived from multiple sources, such as two or more different strains or species of a microorganism.
[0070] "Wild-type" refers to the typical form of an organism, strain, gene, or trait that occurs in nature, as distinguished from mutant or variant forms.
[0071] "Endogenous" refers to a nucleic acid or protein present or expressed in a wild-type or parental microorganism from which the microorganism of the present disclosure is derived. For example, an endogenous gene is a gene that is naturally present in a wild-type or parental microorganism from which the microorganism of the present disclosure is derived. In one embodiment, the expression of an endogenous gene can be controlled by an exogenous regulatory element, such as an exogenous promoter.
[0072] "Exogenous" refers to a nucleic acid or protein originating from outside the microorganism of the present disclosure. For example, an exogenous gene or enzyme can be artificially or recombinantly produced and introduced into or expressed in a microorganism of the present disclosure. An exogenous gene or enzyme can also be isolated from a heterologous microorganism and introduced into or expressed in a microorganism of the present disclosure. An exogenous nucleic acid can be adapted to integrate into the genome of a microorganism of the present disclosure or to remain in an extrachromosomal state in a microorganism of the present disclosure, for example, a plasmid.
[0073] "Heterologous" refers to a nucleic acid or protein that is not present in the wild-type or parental microorganism from which the microorganism of the present disclosure is derived. For example, a heterologous gene or enzyme may be derived from a different strain or species and introduced into or expressed in the microorganism of the present disclosure. A heterologous gene or enzyme may be introduced into or expressed in the microorganism of the present disclosure in a form in which it occurs in a different strain or species. Alternatively, a heterologous gene or enzyme may be modified in some way, for example, by codon-optimizing it for expression in the microorganism of the present disclosure, or by engineering it to change its function, for example, to reverse the direction of enzyme activity or to change its substrate specificity.
[0074] The terms "polynucleotide", "nucleotide", "nucleotide sequence", "nucleic acid", and "oligonucleotide" are used interchangeably. They refer to polymeric forms of nucleotides of any length, either deoxyribonucleotides or ribonucleotides, or analogs thereof. Polynucleotides can have any three-dimensional structure and can perform any function, known or unknown. The following are non-limiting examples of polynucleotides: coding or non-coding regions of a gene or gene fragment, locus(es) defined from linkage analysis, exons, introns, messenger RNA (mRNA), transfer RNA, ribosomal RNA, short interfering RNA (siRNA), short-hairpin RNA (shRNA), micro-RNA (miRNA), ribozymes, cDNA, recombinant polynucleotides, branched polynucleotides, plasmids, vectors, isolated DNA of any sequence, isolated RNA of any sequence, nucleic acid probes, and primers. Polynucleotides can contain one or more modified nucleotides, such as methylated nucleotides or nucleotide analogs. If present, modifications to the nucleotide structure may be imparted before or after assembly of the polymer. The sequence of nucleotides may be interrupted by non-nucleotide components. A polynucleotide may be further modified after polymerization, such as by conjugation with a labeling component.
[0075] As used herein, "expression" refers to the process by which a polynucleotide is transcribed from a DNA template (e.g., into mRNA or other RNA transcript) and / or the process by which the transcribed mRNA is subsequently translated into a peptide, polypeptide, or protein. The transcripts and the encoded polypeptides may be collectively referred to as "gene product."
[0076] The terms "polypeptide", "peptide" and "protein" are used interchangeably herein to refer to polymers of amino acids of any length. The polymers may be linear or branched, may comprise modified amino acids, and may be interrupted by non-amino acids. The term also encompasses amino acid polymers that have been modified, for example, by disulfide bond formation, glycosylation, lipidation, acetylation, phosphorylation, or any other manipulation, such as conjugation with a labeling component. As used herein, the term "amino acid" includes natural and / or unnatural or synthetic amino acids, including glycine, both D- or L-optical isomers, as well as amino acid analogs and peptidomimetics.
[0077] "Enzyme activity" or simply "activity" broadly refers to enzymatic activity, including, but not limited to, the activity of an enzyme, the amount of an enzyme, or the availability of an enzyme to catalyze a reaction. Thus, "increasing" an enzyme activity includes increasing the activity of an enzyme, increasing the amount of an enzyme, or increasing the availability of an enzyme to catalyze a reaction. Similarly, "reducing" an enzyme activity includes decreasing the activity of an enzyme, decreasing the amount of an enzyme, or decreasing the availability of an enzyme to catalyze a reaction.
[0078] "Mutated" refers to a nucleic acid or protein that is modified in the microorganism of the present disclosure compared to the wild-type or parent microorganism from which the microorganism of the present disclosure is derived. In one embodiment, the mutation may be a deletion, insertion, or substitution in a gene encoding an enzyme. In another embodiment, the mutation may be a deletion, insertion, or substitution of one or more amino acids in an enzyme.
[0079] Specifically, a "disruptive mutation" is a mutation that reduces or eliminates (i.e., "disrupts") the expression or activity of a gene or enzyme. A disruptive mutation may partially inactivate, completely inactivate, or delete a gene or enzyme. A disruptive mutation may be any mutation that reduces, prevents, or inhibits the biosynthesis of a product produced by an enzyme. A disruptive mutation may be a knockout (KO) mutation. A disruption may also be a knockdown (KD) mutation that reduces but does not completely eliminate the expression or activity of a gene, protein, or enzyme. KO is generally effective in increasing product yields, but may result in the disadvantages of growth defects or genetic instability that outweigh the benefits, especially for non-growth-bound products. A disruptive mutation may include, for example, a mutation in a gene encoding an enzyme, a mutation in a genetic regulatory element involved in the expression of a gene encoding an enzyme, the introduction of a nucleic acid that produces a protein that reduces or inhibits the activity of the enzyme, or the introduction of a nucleic acid (e.g., antisense RNA, siRNA, CRISPR) or protein that inhibits the expression of the enzyme. Disruptive mutations may be introduced using any method known in the art.
[0080] The introduction of a disruptive mutation results in the microorganism of the present disclosure not producing the target product, or producing substantially no product, or a reduced amount of the target product, compared to the parental microorganism from which the microorganism of the present disclosure is derived. For example, the microorganism of the present disclosure may not produce the target product, or may produce at least about 1%, 3%, 5%, 10%, 20%, 30%, 40%, 50%, 60%, 70%, 80%, 90%, or 95% less of the target product than the parental microorganism. For example, the microorganism of the present disclosure may produce less than about 0.001, 0.01, 0.10, 0.30, 0.50, or 1.0 g / L of product.
[0081] "Codon optimization" refers to the mutation of a nucleic acid, such as a gene, for optimized or improved translation of the nucleic acid in a particular strain or species. Codon optimization can result in faster translation rate or accuracy of translation. In one embodiment, the genes of the present disclosure are codon optimized for expression in Clostridium, particularly Clostridium autoethanogenum, Clostridium ljungdahlii, or Clostridium ragsdalei. In a further embodiment, the genes of the present disclosure are codon optimized for expression in Clostridium autoethanogenum LZ1561, deposited under DSMZ Accession No. DSM23693.
[0082] "Overexpressed" refers to increased expression of a nucleic acid or protein in a microorganism of the present disclosure compared to the wild-type or parent microorganism from which the microorganism of the present disclosure is derived. Overexpression can be achieved by any means known in the art, including altering gene copy number, gene transcription rate, gene translation rate, or enzyme degradation rate.
[0083] The term "variant" includes nucleic acids and proteins whose sequences vary from those of reference nucleic acids and proteins, such as those disclosed in the prior art or exemplified herein. The present disclosure may be practiced using variant nucleic acids or proteins that perform substantially the same function as the reference nucleic acid or protein. For example, the variant protein may perform substantially the same function or catalyze substantially the same reaction as the reference protein. The variant gene may encode the same or substantially the same protein as the reference gene. The variant promoter may have substantially the same ability to promote expression of one or more genes as the reference promoter.
[0084] Such nucleic acids or proteins may be referred to herein as "functionally equivalent variants". By way of example, functionally equivalent variants of nucleic acids may include allelic variants, gene fragments, mutated genes, polymorphisms, and the like. Homologous genes from other microorganisms are also examples of functionally equivalent variants. These include homologous genes from species such as Clostridium acetobutylicum, Clostridium beijerinckii, or Clostridium ljungdahlii, details of which are publicly available on websites such as Genbank or NCBI. Functionally equivalent variants also include nucleic acids whose sequence has been altered as a result of codon optimization of a particular microorganism. Functionally equivalent variants of nucleic acids preferably have at least about 70%, about 80%, about 85%, about 90%, about 95%, about 98%, or more nucleic acid sequence identity (percent homology) with the reference nucleic acid. A functionally equivalent variant of a protein preferably has at least about 70%, about 80%, about 85%, about 90%, about 95%, about 98% or more amino acid identity (percent homology) with the reference protein. Functional equivalence of a variant nucleic acid or protein can be assessed using any method known in the art.
[0085] "Complementarity" refers to the ability of a nucleic acid to form hydrogen bonds with another nucleic acid sequence, either by conventional Watson-Crick or other non-conventional methods. Percent complementarity indicates the percentage of residues in a nucleic acid molecule that can form hydrogen bonds (e.g., Watson-Crick base pairing) with a second nucleic acid sequence (e.g., 5, 6, 7, 8, 9, 10 out of 10 for 50%, 60%, 70%, 80%, 90%, and 100% complementarity). "Perfect complementarity" means that all contiguous residues of a nucleic acid sequence will hydrogen bond with the same number of contiguous residues of a second nucleic acid sequence. As used herein, "substantial complementarity" refers to a degree of complementarity of at least 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, 97%, 98%, 99%, or 100% over a region of 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 30, 35, 40, 45, 50, or more nucleotides, or two nucleic acids that hybridize under stringent conditions.
[0086] As used herein, "stringent conditions" for hybridization refers to conditions under which a nucleic acid having complementarity to a target sequence will predominantly hybridize to the target sequence and will not substantially hybridize to non-target sequences. Stringent conditions are generally sequence-dependent and vary depending on many factors. Generally, the longer the sequence, the higher the temperature at which it will specifically hybridize to its target sequence. Non-limiting examples of stringent conditions are well known in the art (e.g., Tijssen, Laboratory techniques in biochemistry and molecular biology-hybridization with nucleic acid probes, Second Chapter "Overview of principles of hybridization and the strategy of nucleic acid probe assay," Elsevier, NY, 1993).
[0087] "Hybridization" refers to a reaction in which one or more polynucleotides react to form a complex that is stabilized through hydrogen bonds between the bases of the nucleotide residues. The hydrogen bonds can occur by Watson-Crick base pairing, Hoogsteen binding, or any other sequence-specific manner. The complex may include two strands forming a duplex structure, three or more strands forming a multistranded complex, a single self-hybridizing strand, or any combination of these. A hybridization reaction may constitute a step in a more extensive process, such as the initiation of PCR or the cleavage of a polynucleotide by an enzyme. A sequence that can hybridize to a given sequence is referred to as the "complement" of the given sequence.
[0088] Nucleic acids can be delivered to the microorganisms of the present disclosure using any method known in the art. For example, the nucleic acid can be delivered as naked nucleic acid or can be formulated with one or more agents, such as liposomes. The nucleic acid can be DNA, RNA, cDNA, or a combination thereof, as appropriate. In certain embodiments, restriction inhibitors can be used. Additional vectors can include plasmids, viruses, bacteriophages, cosmids, and artificial chromosomes. In one embodiment, the nucleic acid is delivered to the microorganisms of the present disclosure using a plasmid. By way of example, transformation (including transduction or transfection) can be achieved by electroporation, sonication, polyethylene glycol-mediated transformation, chemical or natural competence, protoplast transformation, prophage induction, or conjugation. In certain embodiments having an active restriction enzyme system, it may be necessary to methylate the nucleic acid before introducing it into the microorganism.
[0089] Additionally, the nucleic acid may be designed to include regulatory elements, such as a promoter, to increase or otherwise control expression of the particular nucleic acid. The promoter may be a constitutive promoter or an inducible promoter. Ideally, the promoter is a Wood-Ljungdahl pathway promoter, a pyruvate, a ferredoxin oxidoreductase promoter, a Rnf complex operon promoter, an ATP synthase operon promoter, or a phosphotransacetylase / acetate kinase operon promoter.
[0090] A "microorganism" is a microscopic organism, particularly a bacterium, an archaea, a virus, or a fungus. The microorganisms of the present disclosure are typically bacteria. As used herein, reference to "microorganism" should be construed as encompassing "bacteria."
[0091] A "parental microorganism" is a microorganism used to generate a microorganism of the present disclosure. A parental microorganism can be a naturally occurring microorganism (i.e., a wild-type microorganism) or a microorganism that has been previously modified (i.e., a mutant or recombinant microorganism). A microorganism of the present disclosure can be modified to express or overexpress one or more enzymes that were not expressed or overexpressed in the parental microorganism. Similarly, a microorganism of the present disclosure can be modified to contain one or more genes that were not contained by the parental microorganism. A microorganism of the present disclosure can also be modified to not express or to express a lower amount of one or more enzymes that were expressed in the parental microorganism. In one embodiment, the parental microorganism is Clostridium autoethanogenum, Clostridium ljungdahlii, or Clostridium ragsdalei. In one embodiment, the parental microorganism is Clostridium autoethanogenum LZ1561, deposited under the terms of the Budapest Treaty at Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH (DSMZ), Inhoffenstrasse 7B, D-38124 Braunschweig, Germany, on June 7, 2010, and assigned the accession number DSM 23693. This strain is described in International Patent Application No. NZ2011 / 000144, published as WO 2012 / 015317.
[0092] The term "derived from" indicates that a nucleic acid, protein, or microorganism is modified or adapted from a different (e.g., parent or wild-type) nucleic acid, protein, or microorganism to produce a new nucleic acid, protein, or microorganism. Such modifications or adaptations typically include insertions, deletions, mutations, or substitutions of nucleic acids or genes. Generally, the microorganisms of the present disclosure are derived from a parent microorganism. In one embodiment, the parent microorganism of the present invention is derived from Clostridium autoethanogenum, Clostridium ljungdahlii, or Clostridium ragsdalei. In one embodiment, the microorganism of the present disclosure is derived from Clostridium autoethanogenum LZ1561, deposited under DSMZ accession number DSM23693.
[0093] The microorganisms of the present disclosure may be further classified based on their functional properties. For example, the microorganisms of the present disclosure may be, or may be derived from, C1-fixing microorganisms, anaerobes, acetogens, ethanologens, carboxydotrophs, and / or methanotrophs. Table 1 provides a representative list of microorganisms and identifies the functional properties of the microorganisms.
[0094] [Table 1] 1 Acetobacterium woodii can produce ethanol from fructose but not from gas. 2 Whether Clostridium magnum can grow in CO has not been investigated. 3 One strain of Moorella thermoacetica, Moorella sp. HUC22-1, has been reported to produce ethanol from gas. 4 Whether Sporomusa ovata can grow in CO has not been investigated. 5 Whether Sporomusa silvacetica can grow in CO has not been investigated. 6 Whether Sporomusa sphaeroides can grow on CO has not been investigated.
[0095] "Wood-Ljungdahl" refers to the Wood-Ljungdahl pathway of carbon fixation, e.g., as described in Ragsdale, Biochim Biophys Acta, 1784:1873-1898, 2008. "Wood-Ljungdahl microorganism" refers to a microorganism that contains the Wood-Ljungdahl pathway, as expected. Generally, the microorganisms of the present disclosure contain the native Wood-Ljungdahl pathway. In this specification, the Wood-Ljungdahl pathway can be the native unmodified Wood-Ljungdahl pathway, or the Wood-Ljungdahl pathway with some degree of genetic modification (e.g., overexpression, heterologous expression, knockout, etc.), so long as it still functions to convert CO, CO2, and / or H2 to acetyl-CoA.
[0096] "C1" refers to a one-carbon molecule, e.g., CO, CO2, CH4, or CH3OH. "C1 oxygenate" refers to a one-carbon molecule, e.g., CO, CO2, or CH3OH, that also contains at least one oxygen atom. "C1 carbon source" refers to a one-carbon molecule that serves as a partial or sole carbon source for the microorganisms of the present disclosure. For example, the C1 carbon source may include one or more of CO, CO2, CH4, CH3OH, or CH2O2. Preferably, the C1 carbon source includes one or both of CO and CO2. "C1 fixing microorganism" is a microorganism that has the ability to produce one or more products from a C1 carbon source. Typically, the microorganisms of the present disclosure are C1 fixing bacteria. In one embodiment, the microorganisms of the present disclosure are derived from the C1 fixing microorganisms identified in Table 1.
[0097] An "anaerobe" is a microorganism that does not require oxygen for growth. Anaerobes may react negatively or die if oxygen is present above a certain threshold. However, some anaerobes can tolerate low levels of oxygen (e.g., 0.000001-5% oxygen). Typically, the microorganisms of the present disclosure are anaerobes. In one embodiment, the microorganisms of the present disclosure are derived from the anaerobes identified in Table 1.
[0098] "Acetogens" are obligate anaerobic bacteria that use the Wood-Ljungdahl pathway as their primary mechanism for energy conservation and synthesis of acetyl-CoA and acetyl-CoA derived products, such as acetate (Ragsdale, Biochim Biophys Acta, 1784:1873-1898, 2008). In particular, acetogens use the Wood-Ljungdahl pathway as a mechanism for (1) reductive synthesis of acetyl-CoA from CO2, (2) terminal electron acceptance, an energy-saving process, and (3) fixation (assimilation) of CO2 in the synthesis of cellular carbon (Drake, Acetogenic Prokaryotes, In: The Prokaryotes, 3rd edition, p.354, New York, NY, 2006). All naturally occurring acetogens are C1 fixing, anaerobic, autotrophic, and non-methanotrophic. Typically, the microorganisms of the present disclosure are acetogens. In one embodiment, the microorganisms of the present disclosure are derived from an acetogen identified in Table 1.
[0099] An "ethanologen" is a microorganism that produces or is capable of producing ethanol. Typically, the microorganisms of the present disclosure are ethanologens. In one embodiment, the microorganisms of the present disclosure are derived from the ethanologens identified in Table 1.
[0100] An "autotroph" is a microorganism capable of growing in the absence of organic carbon. Instead, autotrophs use inorganic carbon sources such as CO and / or CO2. Typically, the microorganisms of the present disclosure are autotrophs. In one embodiment, the microorganisms of the present disclosure are derived from the autotrophs identified in Table 1.
[0101] A "carboxydotroph" is a microorganism capable of utilizing CO as a sole source of carbon and energy. Typically, the microorganisms of the disclosure are carboxydotrophs. In one embodiment, the microorganisms of the disclosure are derived from a carboxydotroph identified in Table 1.
[0102] A "methanotroph" is a microorganism capable of utilizing methane as a sole source of carbon and energy. In certain embodiments, the microorganisms of the disclosure are methanotrophs or are derived from methanotrophs. In other embodiments, the microorganisms of the disclosure are not methanotrophs or are not derived from methanotrophs.
[0103] More broadly, the microorganism of the present disclosure may be derived from any genus or species identified in Table 1. For example, the microorganism may be a member of a genus selected from the group consisting of Acetobacterium, Alkalibaculum, Blautia, Butyribacterium, Clostridium, Eubacterium, Moorella, Oxobacter, Sporomusa, and Thermoanaerobacter. In particular, the microorganism may be derived from a parent bacterium selected from the group consisting of Acetobacterium woodii, Alkalibaculum bacchii, Blautia producta, Butyribacterium methylotrophicum, Clostridium aceticum, Clostridium autoethanogenum, Clostridium carboxidivorans, Clostridium coskatii, Clostridium drakei, Clostridium formicoaceticum, Clostridium ljungdahlii, Clostridium magnum, Clostridium ragsdalei, Clostridium scatologenes, Eubacterium limosum, Moorella thermautotrophica, Moorella thermoacetica, Oxobacter pfennigii, Sporomusa ovata, Sporomusa silvacetica, Sporomusa sphaeroides, and Thermoanaerobacter kivui.
[0104] In one embodiment, the microorganism of the present disclosure is derived from the cluster of Clostridia, including the species Clostridium autoethanogenum, Clostridium ljungdahlii, and Clostridium ragsdalei, which were first reported and characterized by Abrini, Arch Microbiol, 161:345-351, 1994 (Clostridium autoethanogenum), Tanner, Int J System Bacteriol, 43:232-236, 1993 (Clostridium ljungdahlii), and Huhnke, WO 2008 / 028055 (Clostridium ragsdalei).
[0105] These three species share many similarities. In particular, they are all C1-fixing, anaerobic, acetogenic, ethanologenic, and carboxydotrophic members of the genus Clostridium. They have similar genotypes and phenotypes as well as modes of energy-conserving and fermentative metabolism. Furthermore, they cluster within the Clostridium rRNA homology group I with 16S rRNA DNA that is greater than 99% identical, have a DNA G+C content of approximately 22-30 mol%, are Gram-positive, have similar morphology and size (logarithmic growing cells of 0.5-0.7 x 3-5 μm), are mesophilic (grow optimally at 30-37°C), have a similar pH range of approximately 4-7.5 (with an optimum pH of approximately 5.5-6), lack cytochromes, and conserve energy via the Rnf complex. Reduction of carboxylic acids to their corresponding alcohols has also been shown in these species (Perez, Biotechnol Bioeng, 110:1066-1077, 2012). Importantly, all of these species also exhibit robust autotrophic growth on CO2-containing gas, producing ethanol and acetate (or acetic acid) as the main fermentation products, and under certain conditions, small amounts of 2,3-butanediol and lactic acid.
[0106] However, these three species also have some differences. These species were isolated from different sources: Clostridium autoethanogenum from rabbit intestine, Clostridium ljungdahlii from poultry farm waste, and Clostridium ragsdalei from freshwater sediments. These species differ in their utilization of various sugars (e.g., rhamnose, arabinose), acids (e.g., gluconic acid, citric acid), amino acids (e.g., arginine, histidine), and other substrates (e.g., betaine, butanol). Furthermore, these species differ in their nutritional requirements for certain vitamins (e.g., thiamine, biotin). These species have differences in the nucleic acid and amino acid sequences of Wood-Ljungdahl pathway genes and proteins, but the general organization and number of these genes and proteins have been found to be the same in all species (Kopke, Curr Opin Biotechnol, 22:320-325, 2011).
[0107] Thus, in summary, many of the characteristics of Clostridium autoethanogenum, Clostridium ljungdahlii, or Clostridium ragsdalei are not specific to that species, but rather are general characteristics of this cluster of C1-fixing, anaerobic, acetogenic, ethanologenic, and carboxydotrophic members of the Clostridium genus. However, because these species are, in fact, quite different, genetic modification or manipulation of one of these species may not have the same effect in another of these species. For example, differences in growth, performance, or product production may be observed.
[0108] The microorganisms of the present disclosure may also be derived from isolates or mutants of Clostridium autoethanogenum, Clostridium ljungdahlii, or Clostridium ragsdalei. Isolates and mutants of Clostridium autoethanogenum include JA1-1 (DSM10061) (Abrini, Arch Microbiol, 161:345-351, 1994), LZ1560 (DSM19630) (WO 2009 / 064200), and LZ1561 (DSM23693) (WO 2012 / 015317). Isolates and mutants of Clostridium ljungdahlii include ATCC49587 (Tanner, Int J Syst Bacteriol, 43:232-236, 1993), PETCT (DSM13528, ATCC55383), ERI-2 (ATCC55380) (U.S. Pat. No. 5,593,886), C-01 (ATCC55988) (U.S. Pat. No. 6,368,819), O-52 (ATCC55989) (U.S. Pat. No. 6,368,819), and OTA-1 (Tirado-Acevedo, Production of bioethanol from synthetic gas using Clostridium ljungdahlii, PhD thesis, North Carolina State University, 2010). Isolates and variants of Clostridium ragsdalei include PI 1 (ATCC BAA-622, ATCC PTA-7826) (WO 2008 / 028055).
[0109] "Substrate" refers to a carbon and / or energy source for the microorganisms of the present disclosure. Generally, the substrate is gaseous and includes a C1 carbon source, such as CO, CO2, and / or CH4. Preferably, the substrate includes a C1 carbon source of CO or CO+CO2. The substrate may further include other non-carbon components such as H2, N2, or electrons.
[0110] The substrate generally contains at least some amount of CO, such as about 1, 2, 5, 10, 20, 30, 40, 50, 60, 70, 80, 90, or 100 mol% CO. The substrate may contain a range of CO, such as about 20-80, 30-70, or 40-60 mol% CO. Preferably, the substrate contains about 40-70 mol% CO (e.g., steel mill or blast furnace gas), about 20-30 mol% CO (e.g., basic oxygen blast furnace gas), or about 15-45 mol% CO (e.g., synthesis gas). In some embodiments, the substrate may contain relatively low amounts of CO, such as about 1-10 or 1-20 mol% CO. The microorganisms of the present disclosure typically convert at least a portion of the CO in the substrate to products. In some embodiments, the substrate is free or substantially free (less than 1 mol%) of CO.
[0111] The substrate may contain some amount of H2. For example, the substrate may contain about 1, 2, 5, 10, 15, 20, or 30 mol% H2. In some embodiments, the substrate may contain relatively large amounts of H2, such as about 60, 70, 80, or 90 mol% H2. In further embodiments, the substrate is free or substantially free (less than 1 mol%) of H2.
[0112] The substrate may contain some amount of CO2. For example, the substrate may contain about 1-80 or 1-30 mol% CO2. In some embodiments, the substrate may contain less than about 20, 15, 10, or 5 mol% CO2. In other embodiments, the substrate is free or substantially free (less than 1 mol%) of CO2.
[0113] Although the substrate is typically gaseous, the substrate may also be provided in alternative forms. For example, the substrate may be dissolved in a liquid saturated with a CO2-containing gas using a microbubble dispersion generator. As a further example, the substrate may be adsorbed onto a solid support.
[0114] The substrate and / or C1 carbon source may be obtained as a by-product of an industrial process, such as from automobile exhaust or biomass gasification, or may be waste gas from some other source. In certain embodiments, the industrial process is selected from the group consisting of ferrous metal product production, such as steel mill production, non-ferrous metal product production, petroleum refining, coal gasification, power generation, carbon black production, ammonia production, methanol production, and coke production. In these embodiments, the substrate and / or C1 carbon source may be captured from the industrial process before it is released into the atmosphere using any convenient method.
[0115] The substrate and / or C1 carbon source may be a synthesis gas, such as synthesis gas obtained by gasification of coal or smelting residues, gasification of biomass or lignocellulosic materials, or reforming of natural gas. In another embodiment, the synthesis gas may be obtained from gasification of municipal solid waste or industrial solid waste. The substrate and / or C1 carbon source may be derived from pyrolysis with or without subsequent partial oxidation of the pyrolysis oil.
[0116] The composition of the substrate can have a significant effect on the efficiency and / or cost of the reaction. For example, the presence of oxygen (O2) can reduce the efficiency of an anaerobic fermentation process. Depending on the composition of the substrate, it may be desirable to treat, scrub, or filter the substrate to remove any undesirable impurities, such as toxins, undesirable components, or dust particles, and / or to increase the concentration of desired components.
[0117] In certain embodiments, the presence of hydrogen results in an improvement in the overall efficiency of the fermentation process.
[0118] The syngas composition can be improved to provide a desired or optimal H2:CO:CO2 ratio. The syngas composition can be improved by adjusting the feedstock fed to the gasification process. The desired H2:CO:CO2 ratio depends on the desired fermentation product of the fermentation process. For ethanol, to meet the stoichiometry for ethanol production, the optimal H2:CO:CO2 ratio is:
[0119]
number
[0120]
number
[0121] Operating a fermentation process in the presence of hydrogen has the added benefit of reducing the amount of CO2 produced by the fermentation process. For example, a gaseous substrate containing minimal H2 will typically produce ethanol and CO2 with the following stoichiometry [6CO+3H2O→C2H5OH+4CO2]. If the amount of hydrogen utilized by the C1 fixing bacteria is increased, the amount of CO2 produced decreases [e.g., 2CO+4H2→C2H5OH+H2O].
[0122] If CO is the sole carbon and energy source for ethanol production, a portion of the carbon will be lost to CO2 as follows: 6CO+3H2O→C2H5OH+4CO2(ΔG°=-224.90kJ / mol ethanol)
[0123] As the amount of H2 available in the substrate increases, the amount of CO2 produced decreases. At a stoichiometric ratio of 2:1 (H2:CO), CO2 production is avoided entirely. 5CO+1H2+2H2O→1C2H5OH+3CO2(ΔG°=-204.80kJ / mol ethanol) 4CO+2H2+1H2O→1C2H5OH+2CO2(ΔG°=-184.70kJ / mol ethanol) 3CO+3H2→1C2H5OH+1CO2(ΔG°=-164.60kJ / mol ethanol)
[0124] "Stream" refers to any substrate that can be passed, for example, from one process to another, from one module to another, and / or from one process to a carbon capture means.
[0125] As used herein, "reactant" refers to a substance that participates in and is changed during a chemical reaction. In certain embodiments, reactants include, but are not limited to, CO and / or H2.
[0126] As used herein, "microbial inhibitors" refers to one or more compositions that slow down or prevent a particular chemical reaction or another process involving microorganisms. In certain embodiments, microbial inhibitors include, but are not limited to, oxygen (O2), hydrogen cyanide (HCN), acetylene (C2H2), and BTEX (benzene, toluene, ethylbenzene, xylene).
[0127] As used herein, "catalytic inhibitor," "sorbent inhibitor," and the like refer to one or more substances that slow down the rate of or prevent a chemical reaction. In certain embodiments, catalytic and / or absorbent inhibitors may include, but are not limited to, hydrogen sulfide (HS) and carbonyl sulfide (COS).
[0128] "Abatement process", "ablation module", "clean-up module", and the like include technologies that can either convert and / or remove microbial and / or catalytic inhibitors from a gas stream. In certain embodiments, catalytic inhibitors must be removed by an upstream abatement module to prevent inhibition of one or more catalysts in a downstream abatement module.
[0129] As used herein, the terms "constituents", "contaminants" and the like refer to microbial and / or catalytic inhibitors that may be found in a gas stream. In certain embodiments, constituents include, but are not limited to, sulfur compounds, aromatic compounds, alkynes, alkenes, alkanes, olefins, nitrogen compounds, phosphorus-containing compounds, particulate matter, solids, oxygen, halogenated compounds, silicon-containing compounds, carbonyls, metals, alcohols, esters, ketones, peroxides, aldehydes, ethers, and tars.
[0130] Terms such as "treated gas" and "treated stream" refer to a gas stream that has passed through at least one removal module and has had one or more constituents removed and / or transformed.
[0131] The term "desired composition" is used to refer to the desired concentration and type of components in a substance, such as a gas stream, including, but not limited to, syngas. More specifically, the gas may be mixed with a gas stream that is mixed with the desired concentration and type of components, such as CO, H 2、 and / or CO2), and / or contains certain components in certain proportions, and / or does not contain certain components (e.g., contaminating components that are harmful to microorganisms), and / or does not contain certain components in certain proportions. In determining whether a gas stream has a desired composition, multiple components may be considered.
[0132] The composition of the substrate can have a significant effect on the efficiency and / or cost of the reaction. For example, the presence of oxygen (O2) can reduce the efficiency of an anaerobic fermentation process. Depending on the composition of the substrate, it may be desirable to treat, scrub, or filter the substrate to remove any undesirable impurities, such as toxins, undesirable components, or dust particles, and / or to increase the concentration of desired components.
[0133] As used herein, the term "carbon capture" refers to the sequestration of carbon compounds, including CO and / or CO, from streams containing CO and / or CO, and Converting CO2 and / or CO into products; or Converting CO2 and / or CO into substances suitable for long-term storage; or sequestering the CO2 and / or CO in a material suitable for long-term storage; Or any combination of these processes.
[0134] In certain embodiments, the fermentation is carried out in the absence of a carbohydrate substrate, such as sugar, starch, lignin, cellulose, or hemicellulose.
[0135] The microorganisms of the present disclosure can be cultured with a gaseous substrate to produce one or more products. For example, the microorganisms of the present disclosure can produce ethanol (WO 2007 / 117157), acetate (WO 2007 / 117157), 1-butanol (WO 2008 / 115080, WO 2012 / 053905, and WO 2017 / 066498), butyrate (WO 2008 / 115080), 2,3-butanediol (WO 2009 / 151342 and WO 2016 / 094334), in addition to 2-phenylethanol. Lactate (WO 2011 / 112103), butene (WO 2012 / 024522), butadiene (WO 2012 / 024522), methyl ethyl ketone (2-butanone) (WO 2012 / 024522 and WO 2013 / 185123), ethylene (WO 2012 / 026833), acetone (WO 2012 / 115527), isopropanol (WO 2012 / 115527), lipids (WO 2013 / 03 6147), 3-hydroxypropionate (3-HP) (WO 2013 / 180581), terpenes including isoprene (WO 2013 / 180584), fatty acids (WO 2013 / 191567), 2-butanol (WO 2013 / 185123), 1,2-propanediol (WO 2014 / 036152), 1-propanol (WO 2017 / 066498), 1-hexanol (WO 2017 / 066498), 1-octyl alcohol (WO 2017 / 066498), 1-propanol (WO 2017 / 066498), 1-octyl alcohol ... No. 2017 / 066498), Chorismart derived products (WO 2016 / 191625), 3-hydroxybutyrate (WO 2017 / 066498), 1,3-butanediol (WO 2017 / 066498), 2-hydroxyisobutyrate or 2-hydroxyisobutyric acid (WO 2017 / 066498), isobutylene (WO 2017 / 066498), adipic acid (WO 2017 / 066498), 1,The microbial biomass may produce or be engineered to produce 3-hexanediol (WO 2017 / 066498), 3-methyl-2-butanol (WO 2017 / 066498), 2-buten-1-ol (WO 2017 / 066498), isovalerate (WO 2017 / 066498), isoamyl alcohol (WO 2017 / 066498), and monoethylene glycol (WO 2019 / 126400). In certain embodiments, the microbial biomass itself may be considered a product. These products may be further converted to produce at least one component of diesel, jet fuel, and / or gasoline. In certain embodiments, 2-phenylethanol may be used as an ingredient in fragrances, essential oils, flavorings, and soaps. Additionally, the microbial biomass may be further processed to produce single cell protein (SCP). ,
[0136] "Single-cell protein" (SCP) refers to microbial biomass that can be used in protein-rich human and / or animal feed, often replacing traditional protein supplement sources such as soybean or fish meal. To produce single-cell protein or other products, the method may include additional separation, processing, or treatment steps. For example, the method may include sterilizing the microbial biomass, centrifuging the microbial biomass, and / or drying the microbial biomass. In certain embodiments, the microbial biomass is dried using spray drying or paddle drying. Because ingestion of a diet high in nucleic acid content can result in accumulation of nucleic acid degradation products and / or gastrointestinal disorders, the method may also include reducing the nucleic acid content of the microbial biomass using any method known in the art. The single-cell protein may be suitable for feeding animals, such as livestock and pets. In particular, the animal feed may be suitable for feeding one or more of beef cattle, dairy cattle, pigs, sheep, goats, horses, mules, donkeys, deer, buffalo / bison, llamas, alpacas, reindeer, camels, banteng, gayal, yaks, chickens, turkeys, ducks, geese, quails, guinea fowl, pigeons / pigeons, fish, shrimp, crustaceans, cats, dogs, and rodents. The composition of the animal feed may be tailored to the nutritional requirements of different animals. Additionally, the method may include mixing or combining the microbial biomass with one or more excipients.
[0137] "Excipient" may refer to any substance that may be added to microbial biomass to enhance or modify the form, characteristics, or nutritional content of an animal feed. For example, an excipient may include one or more of carbohydrates, fiber, fat, protein, vitamins, minerals, water, flavors, sweeteners, antioxidants, enzymes, preservatives, probiotics, or antibiotics. In some embodiments, an excipient may be hay, straw, silage, grain, oil or fat, or other plant material. An excipient may be any feed component identified in Chiba, Section 18: Diet Formulation and Common Feed Ingredients, Animal Nutrition Handbook, 3rd revision, pages 575-633, 2014.
[0138] A "natural product" is a product produced by a non-genetically modified microorganism. For example, ethanol, acetate, and 2,3-butanediol are natural products of Clostridium autoethanogenum, Clostridium ljungdahlii, and Clostridium ragsdalei. A "non-natural product" is a product that is produced by a genetically modified microorganism but is not produced by the non-genetically modified microorganism from which the genetically modified microorganism is derived.
[0139] "Selectivity" refers to the ratio of production of a target product to the production of all fermentation products produced by a microorganism. The microorganisms of the present disclosure can be engineered to produce a product with a certain selectivity or with a minimum selectivity. In one embodiment, the target product accounts for at least about 5%, 10%, 15%, 20%, 30%, 50%, or 75% of the total fermentation products produced by the microorganisms of the present disclosure. In one embodiment, the target product accounts for at least 10% of the total fermentation products produced by the microorganisms of the present disclosure, such that the microorganisms of the present disclosure have selectivity for at least 10% of the target product. In another embodiment, the target product accounts for at least 30% of the total fermentation products produced by the microorganisms of the present disclosure, such that the microorganisms of the present disclosure have selectivity for at least 30% of the target product.
[0140] "Increasing efficiency," "increased efficiency," and the like include, but are not limited to, increasing growth rate, product production rate or volume, product volume per volume of substrate consumed, or product selectivity. Efficiency may be measured relative to the performance of a parental microorganism from which the microorganism of the present disclosure is derived.
[0141] Typically, the cultivation is carried out in a bioreactor. The term "bioreactor" includes a cultivation / fermentation device consisting of one or more vessels, towers, or piping arrangements, such as a continuous stirred tank reactor (CSTR), immobilized cell reactor (ICR), trickle bed reactor (TBR), bubble column, gas lift fermenter, static mixer, or other vessel or device suitable for gas-liquid contact. In some embodiments, the bioreactor may include a first growth reactor and a second cultivation / fermentation reactor. Substrate may be provided to one or both of these reactors. As used herein, the terms "cultivation" and "fermentation" are used interchangeably. These terms encompass both the growth and product biosynthesis phases of the cultivation / fermentation process.
[0142] The cultures are generally maintained in an aqueous medium containing sufficient nutrients, vitamins, and / or minerals to allow growth of the microorganism. Preferably, the aqueous medium is an anaerobic microbial medium, such as a minimal anaerobic microbial growth medium. Suitable media are known in the art.
[0143] Cultivation / fermentation should desirably be carried out under conditions appropriate for the production of the target product. Typically, the cultivation / fermentation is carried out under anaerobic conditions. Reaction conditions to be considered include pressure (or partial pressure), temperature, gas flow rate, liquid flow rate, medium pH, medium redox potential, agitation rate (if using a continuous stirred tank reactor), inoculum level, maximum gas substrate concentration to ensure that the gas in the liquid phase is not limiting, and maximum product concentration to avoid product inhibition. Specifically, the rate of introduction of substrate may be controlled to ensure that the concentration of gas in the liquid phase is not limiting, since the product may be consumed by the cultivation under gas-limited conditions.
[0144] Operating a bioreactor at elevated pressure allows for an increased rate of gas mass transfer from the gas phase to the liquid phase. Therefore, it is generally preferred to carry out the culture / fermentation at a pressure higher than atmospheric pressure. Also, since a given gas conversion rate is in part a function of the substrate retention time, and the retention time dictates the required volume of the bioreactor, the use of a pressurized system can significantly reduce the required bioreactor volume, and therefore the capital cost of the culture / fermentation equipment. This further means that the retention time, defined as the liquid volume in the bioreactor divided by the input gas flow rate, can be reduced when the bioreactor is maintained at a pressure higher than atmospheric pressure. The optimal reaction conditions depend in part on the particular microorganism used. However, it is generally preferred to carry out the fermentation at a pressure higher than atmospheric pressure. Also, since a given gas conversion rate is in part a function of the substrate retention time, and achieving a desired retention time dictates the required volume of the bioreactor, the use of a pressurized system can significantly reduce the required bioreactor volume, and therefore the capital cost of the fermentation equipment.
[0145] In certain embodiments, fermentation is carried out in the absence of light or in the presence of an insufficient amount of light to meet the energy requirements of the photosynthetic microorganisms, hi certain embodiments, the microorganisms of the present disclosure are non-photosynthetic microorganisms.
[0146] As used herein, the term "fermentation broth" or "broth" refers to a mixture of components in a bioreactor, including cells and nutrient medium. As used herein, a "separator" is a module adapted to receive fermentation broth from a bioreactor and pass the broth through a filter to obtain a "retentate" and a "permeate". The filter may be a membrane, e.g., a cross-flow membrane or a hollow fiber membrane. The term "permeate" is used to refer to the substantially soluble components of the broth that pass through the separator. The permeate typically contains soluble fermentation products, by-products, and nutrients. The retentate typically contains cells. As used herein, the term "broth bleed" is used to refer to a portion of the fermentation broth that is removed from the bioreactor and is not passed through the separator.
[0147] The target product can be separated or purified from the fermentation broth using any method or combination of methods known in the art, including, for example, fractional distillation, evaporation, pervaporation, gas stripping, phase separation, and extractive fermentation, including, for example, liquid-liquid extraction. In certain embodiments, the target product is recovered from the fermentation broth by continuously removing a portion of the broth from the bioreactor, separating the microbial cells from the broth (conveniently by filtration), and recovering one or more target products from the broth. Alcohol and / or acetone can be recovered, for example, by distillation. Acids can be recovered, for example, by adsorption on activated carbon. The separated microbial cells are preferably recycled back to the bioreactor. The cell-free permeate remaining after the target product is removed is also preferably returned to the bioreactor. Additional nutrients can be added to the cell-free permeate to replenish the medium before being returned to the bioreactor.
[0148] As referred to herein, a "shuttle microorganism" is a microorganism in which a methyltransferase enzyme is expressed and which is distinct from the destination microorganism.
[0149] As referred to herein, a "destination microorganism" is a microorganism in which the genes contained in an expression construct / vector are expressed and is distinct from the shuttle microorganism. It is also called the host microorganism.
[0150] The term "main fermentation product" is intended to mean one fermentation product that is produced in the highest concentration and / or yield. There may be more than one fermentation product. The most prevalent may or may not be the most commercially valuable.
[0151] The phrase "substrate comprising carbon monoxide" and similar terms should be understood to include any substrate in which carbon monoxide is available to one or more strains of bacteria, for example, for growth and / or fermentation.
[0152] The phrase "gaseous substrate comprising carbon monoxide" and similar phrases and terms include any gas that contains some level of carbon monoxide. In certain embodiments, the substrate contains at least about 20% to about 100% CO by volume, 20% to 70% CO by volume, 30% to 60% CO by volume, and 40% to 55% CO by volume. In certain embodiments, the substrate contains about 25% by volume, or about 30% by volume, or about 35% by volume, or about 40% by volume, or about 45% by volume, or about 50% by volume CO, or about 55% by volume CO, or about 60% by volume CO.
[0153] Although it is not necessary for the CO-containing substrate to contain any hydrogen, the presence of H2 should not be detrimental to product formation by the disclosed methods. In certain embodiments, the presence of hydrogen results in an improvement in the overall efficiency of alcohol production. For example, in certain embodiments, the substrate may contain about 2:1 or 1:1 or 1:2 ratios of H2:CO. In one embodiment, the substrate contains about 30% H2 by volume or less, 20% H2 by volume or less, about 15% H2 by volume or less, or about 10% H2 by volume or less. In other embodiments, the substrate stream contains low concentrations of H2, for example, less than 5%, or less than 4%, or less than 3%, or less than 2%, or less than 1%, or is substantially free of hydrogen. The substrate may also contain some CO2, for example, about 1% to about 80% CO2 by volume, or 1% to about 30% CO2 by volume. In one embodiment, the substrate contains about 20% CO2 by volume or less. In certain embodiments, the substrate comprises about 15% CO2 by volume or less, about 10% CO2 by volume or less, about 5% CO2 by volume or less, or is substantially free of CO2.
[0154] The phrase "substrate comprising carbon dioxide" and similar terms should be understood to include any substrate in which carbon dioxide is available to one or more strains of bacteria, for example, for growth and / or fermentation. A substrate comprising carbon dioxide may further comprise hydrogen and / or carbon monoxide.
[0155] The phrase "gaseous substrate comprising carbon dioxide" and similar phrases and terms include any gas that contains some level of carbon dioxide. In certain embodiments, the substrate contains at least about 10% to about 60% CO2 by volume, 20% to 50% CO2 by volume, 30% to 60% CO2 by volume, and 40% to 55% CO2 by volume. In certain embodiments, the substrate contains about 20%, about 25%, or about 30%, or about 35%, or about 40%, or about 45%, or about 50% CO2 by volume, or about 55% CO2 by volume, or about 60% CO2 by volume.
[0156] Preferably, the substrate that contains CO also contains some level of CO or H. In certain embodiments, the substrate comprises a CO:H ratio of at least about 1:1, or at least about 1:2, or at least about 1:3, or at least about 1:4, or at least about 1:5.
[0157] In the following description, embodiments of the present disclosure are described with respect to delivering and fermenting a "gaseous substrate containing CO and / or CO2". However, it should be understood that the gaseous substrate may be provided in alternative forms. For example, the gaseous substrate containing CO and / or CO2 may be provided dissolved in a liquid. Essentially, the liquid is saturated with a carbon monoxide-containing gas and then the liquid is added to the bioreactor. This may be accomplished using standard methodologies. As an example, a microbubble dispersion generator (Hensirisak et.al. Scale-up of microbubble dispersion generator for aerobic fermentation; Applied Biochemistry and Biotechnology Volume 101, Number 3 / October 2002) may be used. As a further example, the gaseous substrate containing CO may be adsorbed onto a solid support. Such alternative methods are encompassed by the use of terms such as "substrate containing CO and / or CO2".
[0158] In certain embodiments of the present disclosure, the CO-containing gaseous substrate (or the gaseous substrate comprising CO2 or CO and CO2 or CO2 and H2 and CO) is an industrial off-gas or waste gas. "Industrial waste or off-gas" includes any gas containing CO and / or CO2 produced by an industrial process and should be interpreted broadly to include gases produced as a result of ferrous metal product manufacturing, non-ferrous product manufacturing, petroleum refining processes, coal gasification, biomass gasification, power production, carbon black production, and coke production. Further examples may be provided elsewhere herein.
[0159] Unless the context requires otherwise, phrases such as "fermentation," "fermentation process," or "fermentation reaction" as used herein are intended to encompass both the growth and product biosynthesis phases of the process. As described further herein, in some embodiments, a bioreactor may include a first growth reactor and a second fermentation reactor. Thus, the addition of a metal or composition to a fermentation reaction should be understood to include addition to either or both of these reactors.
[0160] The term "bioreactor" includes fermentation devices consisting of one or more vessels, including continuous stirred tank reactors (CSTRs), immobilized cell reactors (ICRs), trickle bed reactors (TBRs), bubble columns, gas lift fermenters, static mixers, or other vessels or devices suitable for gas-liquid contact, and / or towers, or piping arrangements. In some embodiments, a bioreactor may include a first growth reactor and a second fermentation reactor. Thus, references to additions to a bioreactor or fermentation reaction should be understood to include additions to either or both of these reactors, as appropriate.
[0161] It should be understood that the present disclosure may be practiced using nucleic acids whose sequences differ from those specifically exemplified herein, provided that they perform substantially the same function. For nucleic acid sequences encoding proteins or peptides, this means that the encoded proteins or peptides have substantially the same function. For nucleic acid sequences representing promoter sequences, the variant sequence has the ability to promote the expression of one or more genes. Such nucleic acids may be referred to herein as "functionally equivalent variants". By way of example, functionally equivalent variants of nucleic acids include allelic variants, gene fragments, genes containing mutations (deletions, insertions, nucleotide substitutions, etc.) and / or polymorphisms, etc. Homologous genes from other microorganisms may also be considered as examples of functionally equivalent variants of the sequences specifically exemplified herein.
[0162] These include homologous genes of species such as Clostridium ljungdahlii, Chloroflexus aurantiacus, Metallosphaera, or Sulfolobus spp, details of which are publicly available on websites such as Genbank or NCBI. The phrase "functionally equivalent variant" should also be considered to include nucleic acids whose sequence has been altered as a result of codon optimization of a particular microorganism. As used herein, a "functionally equivalent variant" of a nucleic acid preferably has at least about 70%, preferably about 80%, more preferably about 85%, preferably about 90%, preferably about 95% or more nucleic acid sequence identity with the identified nucleic acid.
[0163] It should also be understood that the present disclosure may be practiced using polypeptides whose sequences differ from the amino acid sequences specifically exemplified herein. These variants may be referred to herein as "functionally equivalent variants." Functionally equivalent variants of proteins or peptides include proteins or peptides that share at least 40%, preferably 50%, preferably 60%, preferably 70%, preferably 75%, preferably 80%, preferably 85%, preferably 90%, preferably 95% or more amino acid identity with the identified protein or peptide and have substantially the same function as the peptide or protein of interest. Such variants include within their scope fragments of proteins or peptides, where the fragments include truncated forms of the polypeptide, where the deletions may be 1-5, 10, 15, 20, 25 amino acids, may extend from residues 1-25 at either end of the polypeptide, and the deletions may be of any length within this region or may be at an internal location. Functionally equivalent variants of the particular polypeptides herein should also be construed to include polypeptides expressed by homologous genes in other species of bacteria, e.g., as exemplified in the preceding paragraph.
[0164] The microorganism of the present disclosure may be prepared from a parent microorganism and one or more exogenous nucleic acids using any number of techniques known in the art for producing recombinant microorganisms. By way of example, transformation (including transduction or transfection) may be achieved by electroporation, sonication, polyethylene glycol-mediated transformation, chemical or natural competence, or conjugation. Suitable transformation techniques are described, for example, in Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning: A laboratory Manual, Cold Spring Harbour Laboratory Press, Cold Spring Harbour, 1989.
[0165] In certain embodiments, due to restriction systems active in the microorganism to be transformed, it is necessary to methylate the nucleic acid to be introduced into the microorganism, which can be done using a variety of techniques, including those described below and further exemplified in the Examples section herein below.
[0166] By way of example, in one embodiment, a recombinant microorganism of the disclosure is produced by a method comprising the following steps: introducing i) an expression construct / vector described herein, and (ii) a methylation construct / vector comprising a methyltransferase gene into a shuttle microorganism, expressing the methyltransferase gene, isolating one or more constructs / vectors from the shuttle microorganism, and introducing one or more constructs / vectors into a destination microorganism.
[0167] In one embodiment, the methyltransferase gene of step B is constitutively expressed. In another embodiment, expression of the methyltransferase gene of step B is inducible.
[0168] The shuttle microorganism is a microorganism, preferably a restriction-negative microorganism, that facilitates methylation of the nucleic acid sequences that constitute the expression construct / vector. In a particular embodiment, the shuttle microorganism is a restriction-negative E. coli, Bacillus subtilis, or Lactococcus lactis.
[0169] The methylation construct / vector comprises a nucleic acid sequence encoding a methyltransferase.
[0170] When the expression construct / vector and the methylation construct / vector are introduced into the shuttle microorganism, the methyltransferase gene present on the methylation construct / vector is induced. Induction may be by any promoter system, but in one particular embodiment of the disclosure, the methylation construct / vector contains an inducible lac promoter and is induced by addition of lactose or an analog thereof, more preferably isopropyl-β-D-thio-galactoside (IPTG). Other suitable promoters include the ara, tet, or T7 systems. In a further embodiment of the disclosure, the methylation construct / vector promoter is a constitutive promoter.
[0171] In a particular embodiment, the methylation construct / vector has an origin of replication specific to the identity of the shuttle microorganism, such that any genes present on the methylation construct / vector are expressed in the shuttle microorganism. Preferably, the expression construct / vector has an origin of replication specific to the identity of the microorganism of interest, such that any genes present on the expression construct / vector are expressed in the microorganism of interest.
[0172] Expression of the methyltransferase enzyme results in methylation of the genes present on the expression construct / vector. The expression construct / vector can then be isolated from the shuttle microorganism according to any one of a number of known methods. By way of example only, the methodology described in the Examples section below can be used to isolate the expression construct / vector.
[0173] In one particular embodiment, both constructs / vectors are isolated simultaneously.
[0174] The expression construct / vector can be introduced into the destination microorganism using any number of known methods. However, by way of example, the methodology described in the Examples section below can be used. Because the expression construct / vector is methylated, the nucleic acid sequence present on the expression construct / vector can be incorporated into the destination microorganism and successfully expressed.
[0175] It is envisioned that the methyltransferase gene may be introduced into the shuttle microorganism and overexpressed. Thus, in one embodiment, the resulting methyltransferase enzyme may be collected using known methods and used in vitro to methylate an expression plasmid. The expression construct / vector may then be introduced into the destination microorganism for expression. In another embodiment, the methyltransferase gene is introduced into the genome of the shuttle microorganism, followed by introducing the expression construct / vector into the shuttle microorganism, isolating one or more constructs / vectors from the shuttle microorganism, and then introducing the expression construct / vector into the destination microorganism.
[0176] It is envisioned that the expression constructs / vectors and methylation constructs / vectors defined above can be combined to provide compositions of matter that are particularly useful for circumventing restriction barrier mechanisms to produce recombinant microorganisms of the present disclosure.
[0177] In a particular embodiment, the expression construct / vector and / or the methylation construct / vector is a plasmid.
[0178] Those skilled in the art will recognize several suitable methyltransferases that are useful in producing the microorganisms of the present disclosure. However, by way of example, the Bacillus subtilis phage ΦT1 methyltransferase and the methyltransferases described in the Examples herein below can be used. Nucleic acids encoding suitable methyltransferases are readily discernable given the sequence and genetic code of the desired methyltransferase.
[0179] Any number of constructs / vectors adapted to allow expression of a methyltransferase gene can be used to generate a methylation construct / vector.
[0180] The present disclosure provides methods for the production of 3-HP, and optionally one or more other products, by microbial fermentation comprising fermenting a substrate comprising CO and / or CO2 using a recombinant microorganism. Preferably, 3-HP is the predominant fermentation product. The methods of the disclosure can be used to reduce overall atmospheric carbon emissions from industrial processes.
[0181] Preferably, the fermentation comprises anaerobically fermenting a substrate in a bioreactor to produce at least 3-HP using a recombinant microorganism of the present disclosure.
[0182] In one embodiment, the method comprises: (a) providing a substrate comprising CO and / or CO2 to a bioreactor containing a culture of one or more microorganisms of the present disclosure; (b) anaerobically fermenting the culture in a bioreactor to produce at least 3-HP.
[0183] In one embodiment, the method comprises: (a) capturing gases containing CO and / or CO2 produced as a result of an industrial process before the gases are released into the atmosphere; (b) anaerobically fermenting the gas containing CO and / or CO2 by a culture containing one or more microorganisms of the present disclosure to produce at least 3-HP.
[0184] In one embodiment, the substrate comprises CO. In one embodiment, the substrate comprises CO2 and CO. In another embodiment, the substrate comprises CO2 and H2. In another embodiment, the substrate comprises CO2, CO and H2.
[0185] In one particular embodiment of the present disclosure, the gaseous substrate fermented by the microorganism is a gaseous substrate containing CO. The gaseous substrate may be a CO-containing waste gas obtained as a by-product of an industrial process or from some other source, such as from automobile exhaust. In particular embodiments, the industrial process is selected from the group consisting of ferrous metal product manufacturing, such as steel mills, non-ferrous metal product manufacturing, petroleum refining processes, coal gasification, power generation, carbon black production, ammonia production, methanol production, and coke production. In these embodiments, the CO-containing gas may be captured from the industrial process before it is released into the atmosphere using any convenient method. CO may be a component of synthesis gas (a gas containing carbon monoxide and hydrogen). CO produced from industrial processes is typically burned to produce CO2, and thus the present disclosure is particularly useful for reducing CO2 greenhouse gas emissions and producing butanol for use as a biofuel. Depending on the composition of the gaseous CO-containing substrate, it may be desirable to treat it to remove any undesirable impurities, such as dust particles, before introducing it into the fermentation. For example, the gaseous substrate may be filtered or washed using known methods.
[0186] In certain embodiments of the present disclosure, the gaseous substrate fermented by the microorganism is a gaseous substrate comprising CO2 and H2. The CO2 / H2-containing substrate may be a waste gas obtained as a by-product of an industrial process. In certain embodiments, the industrial process is selected from the group consisting of hydrogen production. In certain embodiments, the gaseous substrate comprising CO2 and H2 may be a mixed gas stream, where at least a portion of the gas stream is derived from one or more industrial processes and mixed with at least a portion of CO2 or H2 to optimize the CO2:H2 ratio of the gaseous substrate. This may be particularly beneficial for industrial gas streams that are rich in either CO2 or H2. Examples of industrial processes that produce by-product gas streams that can be used as a source of CO2 and H2 substrates, or CO2 and H2 mixed substrates, include coke production, refinery processes, ammonia production processes, methanol production processes, acetic acid production, natural gas refineries, and power plants.
[0187] It will be appreciated that in order for bacterial growth and conversion of gas to products including 3-HP to occur, a suitable liquid nutrient medium must be fed to the bioreactor in addition to the CO and / or CO2 containing substrate gas. The substrate and medium may be fed to the bioreactor in a continuous, batch or batch-fed manner. The nutrient medium contains sufficient vitamins and minerals to allow growth of the microorganism used. Anaerobic media suitable for fermentation to produce one or more products using CO and / or CO2 are known in the art. For example, suitable media are described in Biebel (2001). In one embodiment of the present disclosure, the media is as described in the Examples section herein below.
[0188] Fermentation should desirably be carried out under conditions suitable for fermentation that support the conversion of gases to products, including 3-HP, to occur. Reaction conditions to consider include pressure (or partial pressure), temperature, gas flow rate, liquid flow rate, medium pH, medium redox potential, agitation rate (if using a continuous stirred tank reactor), inoculum level, maximum gas substrate concentration to ensure that CO and / or CO2 in the liquid phase do not become limiting, and maximum product concentration to avoid product inhibition.
[0189] In addition, it is often desirable to increase the CO and / or CO2 concentration of the substrate stream (or the CO and / or CO2 partial pressure in a gaseous substrate), and thus increase the efficiency of fermentation reactions in which CO and / or CO2 are substrates. Operating at increased pressure allows for a significant increase in the rate at which CO and / or CO2 are transferred from the gas phase to the liquid phase where they can be taken up by the microorganism as a carbon source to make products, including 3-HP. This further means that the retention time, defined as the liquid volume in the bioreactor divided by the input gas flow rate, can be reduced when the bioreactor is maintained at an elevated pressure above atmospheric pressure. Optimal reaction conditions will depend in part on the particular microorganism of the present disclosure used. However, in general, it is preferred to perform the fermentation at a pressure higher than ambient pressure. Also, since the conversion rate of a given CO and / or CO2 to at least 3-HP is in part a function of the substrate retention time, and achieving a desired retention time further dictates the required volume of the bioreactor, the use of a pressurized system can significantly reduce the required bioreactor volume, and consequently the capital costs of the fermentation equipment. According to examples given in U.S. Pat. No. 5,593,886, the reactor volume can be reduced in linear proportion to increases in reactor operating pressure, i.e., a bioreactor operated at 10 atmospheres requires only one-tenth the volume of a bioreactor operated at 1 atmosphere.
[0190] By way of example, the advantages of performing gas-to-ethanol fermentations at high pressure have been described. For example, WO 02 / 08438 describes gas-to-ethanol fermentations carried out at pressures of 30 psig and 75 psig, giving ethanol productivity of 150 g / l / day and 369 g / l / day, respectively. However, exemplary fermentations carried out at atmospheric pressure using similar medium and input gas compositions were found to produce 10-20 times less ethanol per liter per day.
[0191] It is also desirable that the rate of introduction of the CO and / or CO2-containing gaseous substrate is such as to ensure that the concentration of CO and / or CO2 in the liquid phase does not become limiting, since a consequence of a CO and / or CO2-limited condition may be that one or more products are consumed by the culture.
[0192] The composition of a gas stream used to feed a fermentation reaction can have a significant impact on the efficiency and / or cost of that reaction. For example, O2 can reduce the efficiency of an anaerobic fermentation process. Treatment of undesirable or unnecessary gases in stages of the fermentation process before or after fermentation can increase the load on such stages (unnecessary energy can be used to compress gases not needed in the fermentation, relative to the product, including when the gas stream is compressed before entering the bioreactor). Therefore, it may be desirable to treat substrate streams, especially those derived from industrial sources, to remove undesirable components and increase the concentration of desirable components.
[0193] In certain embodiments, the culture of the bacteria of the present disclosure is maintained in an aqueous culture medium.Preferably, the aqueous culture medium is a minimal anaerobic microbial growth medium.Suitable media are known in the art and described, for example, in U.S. Pat. Nos. 5,173,429 and 5,593,886 and WO 02 / 08438, and described in the Examples section herein below.
[0194] 3-HP, or a mixed stream containing 3-HP and / or one or more other products, can be recovered from the fermentation broth by methods known in the art, such as fractional distillation or evaporation, pervaporation, gas stripping, and extractive fermentation, including, for example, liquid-liquid extraction.
[0195] In certain embodiments of the present disclosure, 3-HP and one or more products are recovered from the fermentation broth by continuously removing a portion of the broth from the bioreactor, separating the microbial cells from the broth (conveniently by filtration), and recovering the one or more products from the broth. The alcohol may be conveniently recovered, for example, by distillation. Acetone may be recovered, for example, by distillation. Any acids produced may be recovered, for example, by adsorption on activated carbon. The separated microbial cells are preferably returned to the fermentation bioreactor. The cell-free permeate remaining after any alcohol and acids have been removed is also preferably returned to the fermentation bioreactor. Additional nutrients (such as vitamin B) may be added to the cell-free permeate to replenish the nutrient medium before being returned to the bioreactor.
[0196] Also, if the pH of the broth has been adjusted as described above to enhance the adsorption of acetate to the activated carbon, the pH should be readjusted to a pH similar to that of the broth in the fermentation bioreactor before it is returned to the bioreactor.
[0197] 3-HP may be recovered after fermentation using any suitable methodology, including, but not limited to, pervaporation, reverse osmosis, and liquid extraction techniques.
[0198] One embodiment is directed to a recombinant C1-fixing bacterium capable of producing 3-hydroxypropionic acid (3-HP) from a carbon source comprising a nucleic acid encoding a group of exogenous enzymes including β-alanine pyruvate aminotransferase and malonate semialdehyde reductase.
[0199] 3. The bacterium of embodiment 2, further comprising a nucleic acid encoding a group of exogenous enzymes comprising pyruvate carboxylase, aspartate aminotransferase, and aspartate decarboxylase, wherein the nucleic acid is operably linked to a promoter.
[0200] 3. The bacterium of embodiment 2, further comprising a nucleic acid encoding a group of exogenous enzymes comprising alanine dehydrogenase and 2,3-alanine aminomutase, wherein the nucleic acid is operably linked to a promoter.
[0201] Clostridium autoethanogenum, Clostridium ljungdahlii, Clostridium ragsdalei, Clostridium carboxidivorans, Clostridium drakei, Clostridium scatologenes, Clostridium aceticum, Clostridium formicoaceticum, Clostridium magnum, Butyribacterium methylotrophicum, Acetobacterium woodii, Alkalibaculum bacchii, Blautia producta, Eubacterium limosum, Moorella thermoacetica, Moorella thermautotrophica, Sporomusa ovata, Sporomusa silvacetica, Sporomusa sphaeroides, Oxobacter pfennigii, and Thermoanaerobacter kivui.
[0202] A bacterium according to one embodiment, which is a Clostridium species selected from the group consisting of C. ljungdahlii and C. autoethanogenum.
[0203] The bacterium according to one embodiment, further comprising a nucleic acid encoding acetyl-Coenzyme A carboxylase, which nucleic acid is codon-optimized for expression in the bacterium.
[0204] The bacterium according to one embodiment, wherein the acetyl-Coenzyme A carboxylase is derived from a member of the genus Clostridium, Metallosphaera, Sulfolobus, or Chloroflexus.
[0205] A bacterium according to one embodiment, wherein a nucleic acid encoding a group of exogenous enzymes comprising β-alanine pyruvate aminotransferase and malonate semialdehyde reductase is codon-optimized for expression in the bacterium.
[0206] The bacterium according to one embodiment, further comprising a nucleic acid encoding a group of exogenous enzymes comprising aldehyde:ferredoxin oxidoreductase and alcohol dehydrogenase, wherein the nucleic acid is operably linked to a promoter.
[0207] A bacterium according to one embodiment, wherein the nucleic acid encoding the group of exogenous enzymes enables the production of 1,3-propanediol.
[0208] The bacterium according to one embodiment, further comprising at least one disruptive mutation in a gene encoding an enzyme selected from an aldehyde:ferredoxin oxidoreductase, an alcohol dehydrogenase, or any combination thereof.
[0209] The bacteria according to an embodiment, wherein 3-HP is converted into a material selected from the group consisting of acrylic acid, acrylonitrile, paints, paper, adhesives, textiles, specialty coatings, inks, superabsorbent polymer polyacrylate, 1,3-propanediol, solvents, glues, cosmetics, polytrimethylene terephthalate, 3-hydroxypropionaldehyde, food, feed additives, and any combination thereof.
[0210] 1. A method for converting CO and / or CO2 to 3-hydroxypropionic acid (3-HP), the process comprising passing a gaseous CO-containing and / or CO2-containing substrate through a bioreactor containing a culture of the recombinant C1-fixing bacterium of claim 1 in a culture medium, such that the CO and / or CO2 is converted to 3-HP by the bacteria, and recovering the 3-HP from the bioreactor.
[0211] 2. A method of culturing a bacterium according to one embodiment, comprising growing the bacterium in a medium comprising a gaseous carbon source, the carbon source comprising CO and / or CO2.
[0212] 10. A method of culturing the bacteria of one embodiment, comprising growing the bacteria in a medium comprising an energy source, the energy source comprising CO and / or CO2.
[0213] The method of one embodiment, wherein the culture is strictly anaerobic.
[0214] The method of one embodiment, wherein the culture is strictly anaerobic.
[0215] 10. The method of claim 1, wherein the carbon source comprises industrial waste or off-gas.
[0216] 13. The method of one embodiment, wherein the energy source comprises industrial waste or off-gas.
[0217] The method according to one embodiment, wherein 3-HP is converted into a material selected from the group consisting of acrylic acid, acrylonitrile, paints, paper, adhesives, textiles, specialty coatings, inks, superabsorbent polymer polyacrylates, 1,3-propanediol, solvents, adhesives, cosmetics, polytrimethylene terephthalate, 3-hydroxypropionaldehyde, food, feed additives, and any combination thereof.
[0218] The method according to one embodiment, wherein 3-HP is converted into a material selected from the group consisting of acrylic acid, acrylonitrile, paints, paper, adhesives, textiles, specialty coatings, inks, superabsorbent polymer polyacrylates, 1,3-propanediol, solvents, adhesives, cosmetics, polytrimethylene terephthalate, 3-hydroxypropionaldehyde, food, feed additives, and any combination thereof. EXAMPLES
[0219] The following examples further illustrate the method and compositions of the present disclosure, but should not be construed as in any way limiting its scope.
[0220] In this study, combinatorial analysis of aspartate-1-decarboxylase (PAND), β-alanine pyruvate aminotransferase (BAPAT), γ-aminobutyrate transaminase (GABT), malonate semialdehyde reductase (MSR), 2,3-alanine aminomutase (AAM), alanine transaminase (AT), and alanine dehydrogenase (ALADH) was performed in C1-fixing bacteria to improve the selectivity and production of 3-HP. The genes heterologously expressed in the 3-HP biosynthetic pathway and the following examples are highlighted in Figure 1.
[0221] Example 1. 3-HP resistance of C. autoethanogenum in Schott bottles 3-HP has been shown to be toxic to microorganisms such as Synechococcus elongatus, with a minimum inhibitory concentration of 180 mg / L (Begemann et al., PLoS One. 2013;8:e76594). To study the toxicity of 3-HP to autotrophic growth of C. autoethanogenum, 3-HP challenge experiments (at 0, 0.2, 0.5, 1, 2, 5, and 10 g / L) were performed using a strain lacking the aldehyde:ferredoxin oxidoreductase (AOR) enzyme in Schott bottles with a synthetic gas blend (50% CO, 10% H2, 30% CO2, and 10% N2) (Figure 2). Compared to unchallenged cultures, 5 g / L of 3-HP reduced the growth rate and peak OD 600nm At 10 g / L, 3-HP reduced the peak OD by 40%. 600nm A decrease in the growth rate was observed, accompanied by a more significant decrease in the growth rate. Figure 2A shows the growth profile. Figure 2B shows the peak biomass. Unc = unchallenged; N = 2; error bars = SD.
[0222] Example 2. Conversion of exogenously added 3-HP to 1,3-propanediol (1,3-PDO) in C. autoethanogenum The genome of C. autoethanogenum encodes two AOR enzyme variants, which have been shown to reduce a range of carboxylic acids (including propanoic and butyric acids) to the corresponding aldehydes, after which native alcohol dehydrogenase activity yields alcohol (Liew et al., Metabolic Engineering. 2017:104-114). To test whether C. autoethanogenum can convert 3-HP to 1,3-propanediol (1,3-PDO) via 3-hydroxypropionaldehyde, exogenous 3-HP was added to the growth medium of C. autoethanogenum at a concentration of 25 mM (2.25 g / L) and subjected to autotrophic growth in Schott bottles. As shown in Figure 3, the wild-type (WT) strain of C. autoethanogenum can convert a portion of the added 3-HP to 1,3-PDO at similar molar concentrations. In contrast, the aor deletion strain was unable to produce any 1,3-PDO under the same growth conditions.
[0223] Example 3. Combinatorial analysis of the 3-HP pathway To determine optimal fluxes and gene variants for the biosynthesis of 3-HP, combinatorial assembly of 3-HP pathway genes and promoters using the Golden Gate (GG) method was first performed in Escherichia coli prior to transformation into C1-utilizing microorganisms (Figure 4). To facilitate screening of assemblies, the ccdB toxin-antitoxin counterselectable marker flanked by Golden Gate sites GG1 and GG6 was first cloned into the Clostridium-E. coli shuttle vector pMTL8225 (Heap, J Microbiol Methods, 78:79-85, 2009). These shuttle vectors have precloned Clostridial promoters (shown as P1 in Figure 4) and terminators (shown as T3 in Figure 4). Genes encoding aspartate-1-decarboxylase (PAND), β-alanine pyruvate aminotransferase (BAPAT), γ-aminobutyrate transaminase (GABT), malonate semialdehyde reductase (MSR), and 2,3-alanine aminomutase (AAM) were added to the shuttle vector for GG assembly, along with two donor vectors (pDonor2 and pDonor4) that provide terminator and promoter sequences. The Golden Gate sites and assembly workflow are described in Karim et al. Synthetic Biology. 2020;5(1):ysaa019. The resulting combinatorial plasmid with an ermB antibiotic selection marker has promoters and terminators to express each of MSR, PAND / AAM, and BAPAT / GABT in a segregated manner. The gene variants included in the combinatorial analysis (7xMSR (SEQ ID NOs: 1-7), 5xPAND (SEQ ID NOs: 8-12), 4xBAPAT / GABT (SEQ ID NOs: 13-16), and 2xAAM (SEQ ID NOs: 17-18) are shown in Table 2. When combined with the selection of three clostridial promoters per gene, the total permutations of this combinatorial library is 5292 (from 3 x 7 x 3 x 7 x 3 x 4).
[0224] [Table 2]
[0225] To determine the assembly efficiency of combinatorial plasmids in E. coli and to investigate the combination of promoter and gene variants, 192 plasmids were extracted from the transformed E. coli strain NEB10-β and subjected to sequencing. Analysis of the sequencing results showed an assembly rate of 99%, and all promoter and gene variants used were represented without significant bias. After transformation of these sequence-verified combinatorial plasmids into C. autoethanogenum, a total of 111 combinatorial strains were subjected to autotrophic growth in 12-well plates.
[0226] Growth experiments were carried out in 12-well plates containing 2 mL of minimal medium and 200 kPa of synthetic gas mix (50% CO, 10% H, 30% CO, and 10% N) at 37 °C for 8 days (Figures 5A-C). Broth samples were then taken for biomass measurements and LC-MS analysis to determine the 3-HP titer.
[0227] After 8 days of incubation, the 3-HP combinatorial strains reached biomass concentrations between 0.5 and 1.2 g DCW / L (Figure 5B). Of these 111 combinatorial strains, 33 strains produced more than 1 mg / L of 3-HP. Seven strains produced more than 10 mg / L of 3-HP (17 mg / L was the highest) (Figure 5A). The genotypes of the top 20 3-HP producing strains are shown in Table 3. The 3-HP titers normalized by biomass concentration are shown in Figure 5C.
[0228] [Table 3]
[0229] The 18 3-HP combinatorial strains were further subjected to autotrophic growth in 250 mL Schott bottles containing 10 mL minimal medium in the presence of 150 kPa syngas mix (50% CO, 10% H, 30% CO, and 10% N) at 37°C for 14 days and sampled periodically for biomass measurements and 3-HP analysis. Up to 24.09±7.95 mg / L of 3-HP was detected in these combinatorial strains, compared to only 0.23±0.02 mg / L of 3-HP in the WT control (Figure 6).
[0230] Example 4. 3-HP and 1,3-PDO production from syngas fermentation in a CSTR The 3-HP combinatorial strains "A59B", "B2A", and "A63B" (Table 3) were characterized in a CSTR under batch mode to compare their 3-HP production with WTC. autoethanogenum. Actively growing (early exponential) cultures from Schott bottles were used as inoculum for a 2 L CSTR containing a syngas blend (50% CO, 10% H2, 30% CO2, and 10% N2) at atmospheric pressure. The 3-HP combinatorial strain "A59B" (Table 3) was also characterized in a CSTR under continuous mode.
[0231] Strain A59B achieved a peak biomass concentration of 3.8 g DCW / L (Figure 7A) and reached a peak CO uptake of 3260 mmol / L / d (Figure 7B). In addition to a peak ethanol concentration of 50 g / L (Figure 7A), this strain reached a peak 3-HP titer of 278.5 mg / L and a peak 1,3-PDO titer of 99.5 mg / L (Figure 7C).
[0232] Strain B2A grew to a peak biomass concentration of 2.7 g DCW / L (Figure 8A) and achieved a peak CO uptake of 2497 mmol / L / d (Figure 8B), while producing a maximum ethanol titer of 16.6 g / L (Figure 8A). During stationary growth phase, peak 3-HP titers of 144.2 mg / L and peak 1,3-PDO titers of 148 mg / L were measured using LC-MS and GC-MS, respectively (Figure 8C).
[0233] Strain A63B achieved a peak biomass concentration of 1.3 g DCW / L (FIG. 9A) and reached a peak CO uptake of 880 mmol / L / d (FIG. 9B). Despite the low peak CO gas uptake, this strain was able to produce a maximum ethanol titer of 23.5 g / L (FIG. 9A), a peak 3-HP titer of 99.2 mg / L, and a peak 1,3-PDO concentration of 40.2 mg / L (FIG. 9C).
[0234] Under continuous CSTR conditions using strain A59B, a dilution (D) rate of 0.5 / day was initiated on day 1.2, then increased to a D of 0.75 / day on day 2.2, eventually reaching a D of 1 / day between days 3.9 and 12. Biomass concentration accumulated to a peak concentration of 4.6 g DCW / L (Figure 10A) and CO gas uptake reached a peak of 3574 mmol / L / d (Figure 10B). Following the switch to a D of 1 / day, the strain achieved peak prolificacy of 358 mg / L / d 3-HP on day 5 and 82.2 mg / L / d 1,3-PDO on day 7 (Figure 10C).
[0235] All references, including publications, patent applications, and patents, cited herein are incorporated by reference to the same extent as if each reference was individually and specifically indicated to be incorporated by reference and was set forth in its entirety herein. The reference to any prior art herein is not, and should not be construed as, an acknowledgment that that prior art forms part of the common general knowledge in the field of endeavor in any country.
[0236] In the context of describing this disclosure (particularly in the context of the claims that follow), the use of the terms "a" and "an" and "the" and similar referents shall be construed to encompass both the singular and the plural, unless otherwise indicated herein or clearly contradicted by context. The terms "comprising," "having," "including," and "containing" shall be construed as open-ended terms (i.e., meaning "including, but not limited to"), unless otherwise noted. The term "consisting essentially of" limits the scope of a composition, process, or method to certain materials, or steps, or those that do not materially affect the basic and novel characteristics of the composition, process, or method. The use of alternative terms (e.g., "or") shall be understood to mean either one, both, or any combination thereof of the alternative terms. As used herein, the term "about" means ±20% of the indicated range, value, or structure, unless otherwise indicated.
[0237] The recitation of ranges of values herein is intended merely to serve as a shorthand method of referring individually to each individual value falling within the range, unless otherwise indicated herein, and each individual value is incorporated herein as if it were individually recited herein. For example, any concentration range, percentage range, ratio range, integer range, size range, or thickness range should be understood to include any integer value within the recited range, and, where appropriate, fractions thereof (such as tenths and hundredths of integers), unless otherwise indicated herein.
[0238] All methods described herein may be performed in any suitable order unless otherwise indicated herein or clearly contradicted by context. The use of any and all examples or exemplary language (e.g., "etc.") provided herein is intended merely to better elucidate the invention and does not limit the scope of the invention unless otherwise asserted. No language in this specification should be construed as indicating any non-claimed element essential to the practice of the disclosure.
[0239] Embodiments of the present disclosure are described herein. Variations of those embodiments may become apparent to those skilled in the art upon reading the above description. The inventors anticipate that those skilled in the art will adopt such variations as necessary, and the inventors intend for the present disclosure to be practiced otherwise than as specifically described herein. Accordingly, the present disclosure includes all modifications and equivalents of the subject matter recited in the claims appended hereto as permitted by applicable law. Moreover, any combination of the above-described elements in all possible variations thereof is encompassed by the present disclosure unless otherwise indicated herein or otherwise clearly contradicted by context. Various embodiments of the present invention are presented below. 1. A recombinant C1 fixing bacterium capable of producing 3-hydroxypropionic acid (3-HP) from a carbon source, comprising a nucleic acid encoding a group of exogenous enzymes including β-alanine pyruvate aminotransferase and malonate semialdehyde reductase. 2. The bacterium according to claim 1, further comprising a nucleic acid encoding a group of exogenous enzymes including pyruvate carboxylase, aspartate aminotransferase, and aspartate decarboxylase, said nucleic acid being operably linked to a promoter. 3. The bacterium according to claim 1, further comprising a nucleic acid encoding a group of exogenous enzymes including alanine dehydrogenase and 2,3-alanine aminomutase, said nucleic acid being operably linked to a promoter. 4.Clostridium autoethanogenum, Clostridium ljungdahlii, Clostridium ragsdalei, Clostridium carboxidivorans, Clostridium drakei, Clostridium scatologenes, Clostridium aceticum, Clostridium formicoaceticum, Clostridium magnum, Butyribacterium methylotrophicum, Acetobacterium woodii, Alkalibaculum bacchii, Blautia producta, Eubacterium limosum, Moorella thermoacetica, Moorella thermautotrophica, Sporomusa ovata, Sporomusa silvacetica, Sporomusa sphaeroides, Oxobacter pfennigii, and Thermoanaerobacter kivui. 5. The bacterium described in 4 above, which is a Clostridium species selected from the group consisting of C. ljungdahlii and C. autoethanogenum. 6. The bacterium described in claim 1, further comprising a nucleic acid encoding acetyl-Coenzyme A carboxylase, said nucleic acid being codon-optimized for expression in said bacterium. 7. The bacterium according to claim 6, wherein the acetyl-Coenzyme A carboxylase is derived from a member of the genus Clostridium, Metallosphaera, Sulfolobus, or Chloroflexus. 8. The bacterium described in 1 above, wherein the nucleic acid encoding a group of exogenous enzymes including β-alanine pyruvate aminotransferase and malonate semialdehyde reductase is codon-optimized for expression in the bacterium. 9. The bacterium described in 1 above, further comprising a nucleic acid encoding a group of exogenous enzymes including aldehyde:ferrodoxin oxidoreductase and alcohol dehydrogenase, said nucleic acid being operably linked to a promoter. 10. The bacterium according to claim 9, wherein the nucleic acid encoding a group of exogenous enzymes enables the production of 1,3-propanediol. 11. The bacterium described in claim 1, wherein 3-HP is converted into a material selected from the group consisting of acrylic acid, acrylonitrile, paints, paper, adhesives, textiles, specialty coatings, inks, superabsorbent polymer polyacrylate, 1,3-propanediol, solvents, glues, cosmetics, polytrimethylene terephthalate, 3-hydroxypropionaldehyde, food, feed additives, and any combination thereof. 12. Gaseous CO-containing and / or CO 2 The CO and / or CO2-containing substrate is passed through a bioreactor containing a culture of the recombinant C1-fixing bacteria described in 1 above in a culture medium, and the bacteria oxidize the CO and / or CO2. 2 and recovering the 3-HP from the bioreactor. 2 to 3-hydroxypropionic acid (3-HP). 13. Growing the bacterium in a medium containing a gaseous carbon source, wherein the carbon source is CO and / or CO 2 2. A method for culturing the bacterium described in 1 above, comprising: 14. Growing the bacterium in a medium containing an energy source, wherein the energy source is CO and / or CO 2 2. A method for culturing the bacterium described in 1 above, comprising: 15. The method according to claim 13, wherein the culture is strictly anaerobic. 16. The method according to claim 14, wherein the culture is strictly anaerobic. 17. The method according to claim 13, wherein the carbon source comprises industrial waste or off-gas. 18. The method of claim 14, wherein the energy source comprises industrial waste or off-gas. 19. The method of claim 13, wherein 3-HP is converted into a material selected from the group consisting of acrylic acid, acrylonitrile, paints, paper, adhesives, textiles, specialty coatings, inks, superabsorbent polymer polyacrylates, 1,3-propanediol, solvents, adhesives, cosmetics, polytrimethylene terephthalate, 3-hydroxypropionaldehyde, food, feed additives, and any combination thereof. 20. The method of claim 14, wherein 3-HP is converted into a material selected from the group consisting of acrylic acid, acrylonitrile, paints, paper, adhesives, textiles, specialty coatings, inks, superabsorbent polymer polyacrylates, 1,3-propanediol, solvents, adhesives, cosmetics, polytrimethylene terephthalate, 3-hydroxypropionaldehyde, food, feed additives, and any combination thereof.
Claims
1. 1. A recombinant C1-fixing bacterium capable of producing 3-hydroxypropionic acid (3-HP) from a carbon source, comprising a nucleic acid encoding a group of exogenous enzymes consisting of β-alanine pyruvate aminotransferase and malonate semialdehyde reductase, wherein the nucleic acid encoding the β-alanine pyruvate aminotransferase has the nucleotide sequence set forth in SEQ ID NO:
14.
2. 2. The bacterium of claim 1, further comprising a nucleic acid encoding a group of exogenous enzymes consisting of pyruvate carboxylase, aspartate aminotransferase, and aspartate decarboxylase, said nucleic acid being operably linked to a promoter.
3. 2. The bacterium of claim 1, further comprising a nucleic acid encoding a group of exogenous enzymes consisting of alanine dehydrogenase and 2,3-alanine aminomutase, said nucleic acid being operably linked to a promoter.
4. Clostridium autoethanogenum, Clostridium ljungdahlii, Clostridium ragsdalei, Clostridium carboxydivorans, Clostridium drakei, Clostridium scatologenes, Clostridium aceticum, Clostridium formicoaceticum formicoaceticum, Clostridium magnum, Butyribacterium methylotrophicum, Acetobacterium woodii, Alkalibaclum bacchii, Blautia producta, Eubacterium limosum, Moorella thermoacetica, Moorella thermoautotrophica, 2. The bacterium of claim 1, wherein the bacterium is selected from the group consisting of Sporomusa thermautotrophica, Sporomusa ovata, Sporomusa silvacetica, Sporomusa sphaeroides, Oxobacter pfennigii, and Thermoanaerobacter kivui.
5. 5. The bacterium of claim 4, which is a Clostridium species selected from the group consisting of C. ljungdahlii and C. autoethanogenum.
6. 2. The bacterium of claim 1, further comprising a nucleic acid encoding acetyl-Coenzyme A carboxylase, said nucleic acid being codon-optimized for expression in said bacterium.
7. 7. The bacterium of claim 6, wherein the acetyl-Coenzyme A carboxylase is derived from a member of the Clostridium, Metallosphaera, Sulfolobus, or Chloroflexus genera.
8. 2. The bacterium of claim 1, wherein the nucleic acid encoding a group of exogenous enzymes consisting of β-alanine pyruvate aminotransferase and malonate semialdehyde reductase is codon-optimized for expression in the bacterium.
9. 2. The bacterium of claim 1, further comprising a nucleic acid encoding a group of exogenous enzymes consisting of aldehyde:ferrodoxin oxidoreductase and alcohol dehydrogenase, said nucleic acid being operably linked to a promoter.
10. 10. The bacterium of claim 9, wherein the nucleic acid encoding a group of exogenous enzymes enables the production of 1,3-propanediol.
11. 2. The bacterium of claim 1, wherein 3-HP is converted into a material selected from the group consisting of acrylic acid, acrylonitrile, paints, paper, adhesives, textiles, specialty coatings, inks, superabsorbent polymer polyacrylates, 1,3-propanediol, solvents, adhesives, cosmetics, polytrimethylene terephthalate, 3-hydroxypropionaldehyde, food, feed additives, and any combination thereof.
12. Gaseous CO-containing and / or CO 2 2. The CO and / or CO2-containing substrate is passed through a bioreactor containing a culture of the recombinant C1-fixing bacteria of claim 1 in a culture medium, whereby the bacteria produce the CO and / or CO2-containing substrate. 2 and recovering the 3-HP from the bioreactor. 2 to 3-hydroxypropionic acid (3-HP).
13. The bacteria is grown in a medium containing a gaseous carbon source, the carbon source being CO and / or CO 2 A method for culturing the bacterium of claim 1, comprising:
14. The bacterium is grown in a medium containing an energy source, the energy source being CO and / or CO 2 A method for culturing the bacterium of claim 1, comprising:
15. The method of claim 13, wherein the culture is strictly anaerobic.
16. The method of claim 14, wherein the culture is strictly anaerobic.
17. 14. The method of claim 13, wherein the carbon source comprises industrial waste or off-gas.
18. The method of claim 14 , wherein the energy source comprises industrial waste or off-gas.
19. 14. The method of claim 13, wherein 3-HP is converted to a material selected from the group consisting of acrylic acid, acrylonitrile, paints, paper, adhesives, textiles, specialty coatings, inks, superabsorbent polymer polyacrylates, 1,3-propanediol, solvents, adhesives, cosmetics, polytrimethylene terephthalate, 3-hydroxypropionaldehyde, food, feed additives, and any combination thereof.
20. 15. The method of claim 14, wherein 3-HP is converted to a material selected from the group consisting of acrylic acid, acrylonitrile, paints, paper, adhesives, textiles, specialty coatings, inks, superabsorbent polymer polyacrylates, 1,3-propanediol, solvents, adhesives, cosmetics, polytrimethylene terephthalate, 3-hydroxypropionaldehyde, food, feed additives, and any combination thereof.
Citation Information
Patent Citations
Photosynthetic organisms
JP2011516029A
Recombinant microorganisms and their use
JP2015517823A
Production of 3-hydropropionic acid using beta-alanine / pyruvate aminotransferase
US20070107080A1
Compositions and methods for 3-hydroxypropionate bio-production from biomass
US20120041232A1
Genetic modification for production of 3-hydroxypropionic acid
US20120329110A1
